
























marine	 macrolides	 that	 have	 been	 intensively	 investigated	






	 Unfortunately	 the	 isolation	 of	 bryostatin	 from	 natural	
sources	is	still	very	challenging	and	so	the	chemical	synthesis	of	
bryostatins	 has	 been	 of	 considerable	 interest.3	 Many	
approaches	 to	 their	 synthesis	 have	 been	 reported	 in	 the	
literature	over	the	years4	and	several	total	syntheses	have	now	
been	completed.5	These	equate	to	outstanding	contributions	to	
the	 chemistry	of	 natural	 products	 and	highlight	 the	 very	 latest	
techniques	 and	 methodogies	 of	 organic	 synthesis.	 The	 early	
syntheses	 of	 these	 complex	 targets	 were	 substantial	
achievements	in	themselves,	but	they	involved	many	steps	with	
lengthy	linear	routes,	and	did	not	really	deliver	useful	quantities	
of	 bryostatins.	 Recently,	 however,	 this	 situation	 has	 changed	
with	 a	 synthesis	 of	 bryostatin	 1	on	 a	multigramme	 scale.6	 This	
development	may	meet	clinical	needs	and	illustrates	the	power	
of	modern	synthetic	organic	chemistry.	
	 Bryostatins	 are	 believed	 to	 effect	 tumour	 inhibition	 by	




bryostatin	 1	 and	 phorbol	 esters,	 Wender	 postulated	 that	 the	
binding	 of	 bryostatin	 to	 PKCs	 involves	 the	 C1-carbonyl	 group	
together	 with	 the	 C19	 and	 C26	 hydroxyl	 groups	 with	 the	 C3	
hydroxyl	 group	 helping	 to	maintain	 the	 required	 conformation	
by	forming	an	 intramolecular	hydrogen	bond.8	This	analysis	 led	
to	 the	 synthesis	 of	 macrocyclic	 analogues	 of	 bryostatins	 that	
possessed	the	C17-C27	fragment	of	bryostatin	1	so	retaining	the	




this	 area	 culminated	 in	 a	 synthesis	 of	 the	 7-benzyl	 ether	 3	
corresponding	 to	 bryostatin	 10	 2,	 the	 first	 synthesis	 of	 a	
bryostatin	with	no	oxygenation	at	C20.11	
	 Most	of	the	synthetic	analogues	with	nanomolar	binding	are	
complex	macrolides	 with	 C17-C27	 fragments	 corresponding	 to	
those	 found	 in	 the	 natural	 products.	 Despite	 this	 feature	 that	
leads	 to	 potent	 PKC	 binding,	 we	 chose	 to	 investigate	 the	
synthesis	of	 analogues	of	bryostatins	 in	which	 the	 structure	of	
the	 C17-C27	 fragment	 had	 been	modified	 to	 see	whether	 any	
beneficial	 affects	 could	 accrue.	 One	 objective	 was	 to	 see	
whether	 simpler,	 non-macrocyclic,	 compounds	 could	 be	
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or	 tumour	 promoters	 was	 difficult	 to	 predict.	 In	 particular,	 it	
was	decided	to	study	the	synthesis	of	bryostatins	 in	which	two	
fluorine	 substituents	 had	been	 introduced	at	 C20,	 for	 example	
see	 structure	 4	 in	 Fig.	 2.	 These	 compounds	 would	 retain	 the	
structural	 features	 that	 are	 important	 for	 binding,	 i.e	 the	 C1	
carbonyl	group	and	the	hydroxyl	groups	at	C19	and	26.	However	
the	electron	withdrawing	C20	 fluorine	 substituents	would	help	
to	 stabilise	 the	 ring-closed	 hemi-acetal	 tautomer.	 They	 would	
also	 make	 the	 21-methoxycarbonylmethylene	 group	 more	
electrophilic	and	lead	to	an	increase	in	the	pKa	of	the	anomeric	
C19	 hydroxyl	 group	 by	 about	 three	 pKa	 units.	 Perhaps	 most	
importantly,	 they	would	prevent	dehydration,	 i.e.	deactivation,	
involving	 loss	 of	 the	 C19	 hydroxyl	 group.	 Fluorinated	 2-
hydroxytetrahydropyrans	 have	 been	 prepared	 as	 surrogates	 of	
monosaccharides,12,13	 and	 analogues	 of	 bryostatin	 with	
fluorinated	B-rings	have	been	synthesized	for	NMR	studies.14	
	 We	 here	 report	 full	 details	 on	 our	 work	 in	 this	 area	 and	









Hydroxyketones	 6	 are	 the	 open-chain	 tautomers	 of	 the	
fluorinated	bryostatin	C-ring	analogues	5.	The	first	approach	to	
these	 compounds	 was	 based	 on	 elaboration	 of	 the	 b-
hydroxyesters	 7	 prepared	 from	 Reformatsky	 reactions17,18	 of	
ethyl	bromodifluoroacetate	as	shown	in	Fig.	3.			
	 The	 Reformatsky	 reaction	 of	 3-(2-mercatobenzothiazolyl)-
2,2-dimethylpropanal	 (8)	 with	 ethyl	 bromodifluoroacetate	 11	
using	activated	copper	dust	gave	the	hydroxyester	12.	This	was	
protected	 as	 its	 triethylsilyl	 ether	 13	 using	 triethylsilyl	
trifluoromethanesulfonate	 and	 the	 ester	 converted	 into	 the	
corresponding	methylketone	18	directly	using	methyllithium	at	





Fig.	 3	 Outline	 of	 the	 first	 approach	 to	 difluorinated	
intermediates	
	
Scheme	 1	 Use	 of	 intermediates	 prepared	 by	 Reformatsky	
reactions	 of	 ethyl	 bromodifluoroacetate	 Reagents	 and	
conditions	 i,	Zn	powder,	CuCl,	THF,	 rt,	30	min,	add	11,	10	min,	
add	 the	 aldehyde	 in	 THF,	 heat	under	 reflux,	 16-36	h	 (12,	 83%;	
13,	75%;	14,	78%);	ii,	2,6-lut.,	TESOTf,	DCM,	rt,	1-10	d	(15,	75%;	





	 The	 intention	 was	 to	 develop	 the	 methyl	 ketone	 18	 to	
introduce	the	required	side-chain,	see	proposed	intermediate	6.	
However,	 an	 attempted	 aldol	 condensation	 with	 (E)-
crotonaldehyde	 gave	 unchanged	 starting	 material	 and	 an	
attempted	 Wittig	 reaction	 to	 convert	 the	 ketone	 into	 the	
corresponding	 alkene	 was	 also	 unsuccessful.	 Since	 these	
difficulties	may	have	been	due	to	the	2-mercaptobenzothiazole,	
3-(benzyloxymethoxy)-2,2-dimethylpropanal	 (9)	 was	 taken	
through	 to	 the	 methylketone	 19.	 The	 Wittig	 reaction	 with	
methylene(triphenyl)phosphorane	now	gave	a	good	yield	of	the	
alkene	21	 and	 the	 same	sequence	was	 successful	 starting	with	
the	3-tert-butyldiphenylsilyloxypropanal	1019,20	giving	the	alkene	
22.	 This	was	 then	 converted	 into	 the	 allylic	 bromide	23	 under	
free-radical	 conditions	 although	 on	 scale-up	 this	 reaction	 was	
somewhat	capricious.	The	intention	had	been	to	use	a	reaction	
of	 the	 allylic	 bromide	 23	 with	 an	 aldehyde	 to	 assemble	
intermediates	 analogous	 to	 the	 target	 compounds	6.	 Although	
modifications	 to	 this	 synthesis	 could	be	envisaged,	 the	 relative	
inaccessability	 of	 bromide	 23	 led	 to	 this	 approach	 being	
discontinued,	see	Scheme	1.	
			 Copper	 catalysed	 coupling	 reactions	 of	 bromo-	 and	 iodo-
difluoroacetates	 with	 aryl	 and	 alkenyl	 iodides	 have	 been	
reported.21,22	This	chemistry	could	lead	to	a	flexible	synthesis	of	
the	 unsaturated	 difluoroesters	24	 from	 the	 alkenyl	 iodides	26,	
see	 Fig.	 4.	 Ozonolysis	 followed	 by	 an	 (E)-selective	 Horner-
Wadsworth-Emmons	reaction	would	introduce	the	required	(E)-
methoxycarbonylmethylene	 group.	 Modification	 of	 the	 ethyl	





















































































 8 X = SBT
 9 X = OBOM
10 X = OTBDPS
12 X = SBT
13 X = OBOM
14 X = OTBDPS
11 15 X = SBT
16 X = OBOM
17 X = OTBDPS
18 X = SBT
19 X = OBOM
20 X = OTBDPS
21 X = OBOM














	 To	access	 the	 intermediate	24	where	R	=	ethyl,	 the	alkenyl	
iodide	 29	 was	 prepared	 from	 the	 alkyne	 27	 by	 addition	 of	
hydrogen	 iodide	 generated	 in	 situ24	 followed	 by	 silylation.	
However,	 in	 our	 hands,	 the	 copper	 catalysed	 coupling	 of	 this	
with	 the	 iododifluoroester	 25	 gave	 only	 a	 low	 yield	 of	 the	
difluorinated	 alkene	30.	 The	 analogous	 coupling	 of	 the	 alkenyl	
iodides	31	 and	32	with	 the	 iododifluoroester	25	 also	 gave	 low	
yields	 of	 the	 products	 33	 and	 34,	 Scheme	 2,	 and	 so	 this	
approach	was	not	taken	any	further.	
			
Scheme	 2	 Attempted	 coupling	 of	 alkenyl	 iodides	 and	 ethyl	
iododifluoroacetate	 Reagents	 and	 conditions	 i,	 NaI,	 TMSCl,	




	 Allyldifluorination	 is	 well	 known	 for	 the	 introduction	 of	
geminal	 difluorine	 containing	 fragments25	 and	 so	 the	
homoallylic	 difluoroalcohols	 36	 should	 be	 readily	 accessible	
from	the	bromodifluoropropene	37	and	aldehydes	38	as	shown	




The	 indium	 powder	 mediated	 reaction25	 of	 3-bromo-3,3-
difluoropropene	 (37)	 with	 3-tert-butyldiphenylsilyloxypropanal	








Scheme	 3	 Preparation	 of	 the	 2-hydroxytetrahydropyran	 44	








further	 oxidation	 of	 the	 resulting	 aldehyde	 gave	 the	




of	 two	 inseparable	 compounds.	 On	 cooling	 a	 single	 product	
crystallised	out	from	this	mixture	and	was	identified	as	the	3,3-
difluoro-2,4-dihydroxytetrahydropyran	 44	 using	 X-ray	
crystallography,	 see	 Fig.	 6.	 On	 standing	 in	 solution	 in	
deuteriated	chloroform	(not	base-washed),	this	hemiacetal	gave	
a	40:60	mixture	in	favour	of	the	second	component	after	10	min	
at	 rt.	 In	 benzene-d6	 or	 in	 base-washed	 chloroform,	 the	
equilibration	took	place	more	slowly	but	gave	a	similar	mixture	
of	the	two	compounds,	typically	within	48	h.	Attempts	to	isolate	
the	 second	 component	 were	 unsuccessful	 as	 the	 initially	
isolated	compound	44	tended	to	crystallise	out.	However,	the	IR	
spectrum	of	a	mixture	did	not	show	a	carbonyl	peak	and	the	1H	
NMR	 spectrum	of	 the	mixture	was	 consistent	with	 the	 second	
component	being	the	epimer	45.	 	It	would	appear	that	the	two	
hemiacetals	 equilibrate	 despite	 the	 presence	 of	 the	 geminal	
fluorine	substituents.	However,	 the	open	chain,	hydroxyketone	
tautomer	 was	 not	 a	 significant	 component	 of	 the	 mixture	 at	
equilibrium.	In	the	crystalline	tautomer	44	the	tert-butyl	and	4-
hydroxyl	 groups	 are	 equatorial	 whereas	 in	 the	 slightly	 more	
stable	epimer	45,	both	hydroxyl	groups	are	axial.				
	 The	reaction	of	prenylmagnesium	chloride	with	the	ester	43	


























11 X = Br
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27 28 P = H
29 P = TBS
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31 P = TBS
32 P = TBDPS
33 P = TBS
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Scheme	 4	 Synthesis	 of	 the	 2-hydroxytetrahydropyran	 47	





component	 identified	 as	 the	 epimeric	 hemiacetal	 48.	 In	 this	
case,	47:48	=	60:40,	at	equilibrium.	Structures	were	assigned	to	
these	 products	 by	 analogy	 with	 the	 2,4-
hydroxytetrahydropyrans	44	and	45.	In	both	cases	the	doublets	
attributed	 to	 the	 fluorines	 were	 significantly	 more	 widely	
separated	in	their	19F	NMR	spectra	for	the	crystalline	epimers	44	
and	47	(see	experimental).		
	 It	 was	 recognised	 that	 2-substituted	 3-bromo-3,3-
difluoropropenes	 49	 could	 react	 with	 aldehydes	 to	 give	
difluoroalkenes	 50,	 see	 Fig.	 7,	 and	 that	 these	 might	 be	
incorporated	 into	C17-C27	 fragments	of	bryostatin	more	easily	
than	 the	 less	 functionalised	 intermediates	 36,	 cf.	 Fig.	 5.	 2-
Substituted	 3-bromo-3,3-difluoropropenes	 have	 been	 used	 in	
palladium-catalysed	reactions	with	aryl	boronic	acids27	but	their	
indium	 mediated	 reactions	 with	 aldehydes	 have	 not	 been	
investigated.			
	 1-Chloro-1,1-difluorodecan-2-one	 (52)	 was	 prepared	 from	
from	 methyl	 chlorodifluoroacetate	 (51)	 according	 to	 the	
literature	procedure.28	Conversion	into	the	epoxide	53	was	then	





under	 reflux,	 isomerisation	 gave	 the	 required	 2-
(bromodifluoromethyl)decene	56	but	only	as	a	mixture	with	the	
starting	bromide,	55	 :	56	 =	20	 :	 80,	 see	Scheme	5.	 The	 indium	
powder	 mediated	 reaction	 of	 this	 mixture	 of	 allylic	 bromides	
with	 benzaldehyde	 gave	 a	modest,	 50%,	 yield	 of	 the	 required	
adduct	 57a.	 However,	 better	 yields	 were	 obtained	 using	 the	
bromide	 55	 and	 the	 yield	 of	 57a	 improved	 to	 84%	 in	 DMF.	












Scheme	 5	 Chemistry	 of	 2-bromomethyl-1,1-difluorodecene	 55	
Reagents	and	conditions	 i,	C8H17MgBr,	Et2O,	 tol.,	-78	oC	to	-20	
oC,	 10	 min	 (96%);	 ii,	 CH2I2,	 MeLi,	 THF,	 -78	 oC	 to	 rt;	 iii,	 tBuLi,	






	 Generally	 Wittig30	 and	 Horner-Wadsworth-Emmons	
reactions23	 of	 a,a-difluorinated	 ketones	 give	 a,b-unsaturated	
esters	 with	 useful	 (E)-stereoselectivity.	 However,	 before	
embarking	on	a	synthesis	of	a	 fluorinated	C17-C27	fragment	of	
bryostatin,	 it	was	decided	 to	 check	 the	 stereoselectivity	of	 the	
introduction	 of	 the	 methoxycarbonylmethylene	 unit	 in	 our	
system,	cf.	Fig.	5.		
	 Oxidation	 of	 the	 previously	 prepared	 alcohols	 40	 and	 57g	
gave	the	ketones	58	and	61.	The	ketoester	63	was	prepared	by	
oxidation	 of	 the	 alcohol	 prepared	 by	 the	 samarium	 di-iodide	
mediated	 Reformatsky	 reaction	 of	 ethyl	 bromodifluoroacetate	
(11)	 and	 the	 protected	 hydroxypropanal	 39.31	 The	 Wittig	
reactions	 of	 the	 ketones	 58	 and	 63	 with	 the	 stabilised	 ylid,	
methoxycarbonylmethylene(triphenyl)phosphorane,	 were	
usefully	 (E)-selective,	 >85:15,	 with	 the	 (E)-ester	 62	 being	 the	
only	product	isolated	from	ketone	61,	see	Scheme	6.		
	 The	(E)-configuration	was	assigned	to	the	major	products	of	
these	 reactions	using	NMR.	For	example,	 the	vinylic	protons	 in	
the	major	 and	minor	 products	 of	 the	 reaction	with	 ketone	 58	
were	 at	 d 6.21	 and	 d 5.98,	 respectively,	 consistent	 with	 the	
vinylic	hydrogen	being	closer	to	the	fluorine	substituents	in	the	
major	 isomer.	 For	 the	 minor	 product,	 significant	 nOe	
enhancement	 of	 a	 5-hydrogen	 was	 observed	 on	 irradiation	 of	
the	vinylic	proton	 consistent	with	 this	being	 the	 (Z)-isomer	60.	
The	 fluorines	 in	 the	 major	 and	 minor	 products	 were	 at	 d	
-100.52	 and	 d	 -95.73	 consistent	 with	 the	 literature23,30	 for	
analogous	 difluorinated	 (E)-	 and	 (Z)-a,b-unsaturated	 esters.	







































































57a R = Ph 
57b R = 4-MeOC6H4 
57c R = 3-ClC6H4 
57d R = nPr 
57e R = iPr 
57f R = tBu 







Scheme	 6	 (E)-Selective	 Wittig	 reactions	 of	 a,a-difluorinated	
ketones	Reagents	and	conditions	i,	TPAP,	NMO,	4Å	sieves,	DCM,	
rt,	16	h	(78%);	ii,	Ph3P=CHCO2Me,	tol.,	70-90	oC,	6-16	h	(59,	84%;	
60,	 11%;	62,	 48%;	64,	 82%;	65,	 12%);	 iii,	DMSO,	 (COCl)2,	DCM,	




	 To	 incorporate	 the	 bis-ester	 64	 into	 a	 synthesis	 of	 a	 2-
hydroxytetrahydropyran	 analogous	 to	 the	 hemiacetal	 47	 (see	
Scheme	4),	 it	would	be	necessary	to	develop	conditions	for	the	
regioselective	 reaction	 of	 prenylmagnesium	 bromide	 with	 the	
ethoxycarbonyl	 group.	 It	 was	 decided	 instead	 to	 attempt	 to	
prepare	 the	 corresponding	 aldehyde	 by	 the	 regioselective	
oxidative	cleavage	of	the	terminal	double	bond	in	the	diene	59	




for	 the	 double	 bond	 conjugated	 to	 the	 ester.	 The	
dihydroxylation	 of	 alkenes	 with	 allylic	 fluorine	 substituents	 by	
osmium	tetroxide	is	known.32		
	 In	 our	 hands	 the	 dihydroxylation	 of	 the	 diene	 59	 using	
osmium	 tetroxide	 and	 N-methylmorpholine-N-oxide	 in	 water-
acetone	was	very	slow	at	rt	and	gave	a	low	yield	of	diol	66	(29%)	
together	with	unchanged	starting	material.	Under	more	forcing	
conditions,	 the	 yield	 improved	 to	 44%	 but	 side-products	 that	
appeared	 to	 have	 been	 formed	 by	 additional	 hydroxylation	 of	
the	 double	 bond	 conjugated	 to	 the	 ester	 were	 also	 detected.	
The	 use	 of	 ruthenium	 tetroxide	 generated	 in	 situ	 by	 the	 slow	
addition	 of	 sodium	 periodate	 to	 a	 solution	 of	 the	 alkene	 and	
ruthenium(III)	chloride33	gave	a	44%	yield	of	the	diol	66	together	
with	 unchanged	 starting	 material.	 This	 procedure	 was	 quite	
reliable	 and	 side	 products	 formed	 by	 hydroxylation	 of	 the	
unsaturated	ester	were	not	isolated,	Scheme	7.			
	 Cleavage	 of	 the	 diol	 66	 using	 lead(IV)	 acetate	 gave	 the	
aldehyde	67.	Rather	than	react	this	with	a	Grignard	reagent,	the	
crude	aldehyde	was	added	to	the	prenyl	bromide	in	THF	and	the	
mixture	 transferred	 to	 a	 suspension	 of	 zinc	 powder	 and	
titanocene	dichloride	in	THF.34	This	procedure	gave	a	reasonable	
yield	 of	 the	 alcohol	 68	 that	 was	 oxidised	 to	 the	 ketone	 69.	





Scheme	 7	 Synthesis	 of	 the	 3,3-difluoro-2-hydroxy-4-[(E)-
methoxycarbonylmethylene]tetrahydropyran	 70	 Reagents	 and	
conditions	i,	RuCl3.H2O,	EtOAc,	MeCN,	H2O,	add	NaIO4	over	5	h,	
rt,	 39	min	 (66,	 44%,	 recovered	59,	 44%);	 ii,	 Pb(OAc)4,	NaHCO3,	
DCM,	 rt,	 30	min;	 iii,	 	 Me2C=CHCH2Br,	 THF,	 add	 to	 Zn	 powder,	
titanocene	 dichloride	 (cat.),	 THF,	 rt,	 2.5	 h	 (65%	 from	 66);	 iv,	
TPAP,	 NMO,	 4Å	 sieves,	 DCM,	 rt,	 30	 min	 (87%);	 v,	 HF.py.,	 py.,	
THF,	rt,	2.5	h	(82%).		
	
	 Structures	were	assigned	 to	 the	 intermediates	 in	Scheme	7	
from	spectroscopic	data	and	by	analogy	with	earlier	work.	The	
hemiacetal	carbon	was	observed	as	a	double-doublet	at	d	99.1	
in	 its	 proton	 decoupled	 13C	 NMR	 spectrum	 due	 to	 slightly	
different	 coupling	 constants	 (2JC-F	 30.1,	 24.4	 Hz)	 with	 the	 axial	
and	equatorial	fluorines.		
This	 synthesis	 had	 given	 the	 3,3-difluoro-2-hydroxy-4-[(E)-
methoxycarbonylmethylene]tetrahydropyran	 70	 in	 eight	 steps	
from	 3-tert-butyldimethylsilylpropanal	 39.	 Although	 the	
hydroxylation	of	 the	alkene	59	was	not	particularly	efficient,	 it	








The	 known	 alkene	7135	was	was	 ozonolysed	with	 reduction	 of	
the	 intermediate	ozonide	using	 triphenylphosphine	 to	 give	 the	
aldehyde	 72.	 The	 indium-mediated	 difluoroallylation	 of	 this	
aldehyde	gave	a	mixture	of	the	epimers	of	alcohol	73.	Samples	
of	 these	 were	 separated	 for	 characterisation	 and	 the	 mixture	
was	oxidised	 to	give	 the	ketone	74.	 The	Wittig	 reaction	of	 this	
ketone	with	methoxycarbonylmethylene(triphenyl)phosphorane	
was	highly	 stereoselective	and	gave	 the	 required	 (E)-alkene	75	
albeit	 with	 a	 small	 amount	 of	 unchanged	 starting	 material.	
Regioselective	 hydroxylation	 of	 the	 diene	 75	 was	 carried	 out	
using	 ruthenium	tetroxide,	and	 the	 resulting	diol	76	was	 taken	
through	to	the	alcohol	77,	as	a	mixture	of	epimers,	by	cleavage	
using	 lead(IV)	 acetate	 and	 reaction	 of	 the	 resulting	 aldehyde	










































































































Ph3P=CHCO2Me,	 tol.,	 90	 oC,	 16	 h	 (75,	 64%;	 74,	 10%),	 v,	 75,	
RuCl3.H2O,	 EtOAc,	MeCN,	 H2O,	 add	 NaIO4	 over	 9	 h	 (76,	 55:45,	
61%;	75,	 39%);	 vi,	 (a)	 NaHCO3,	 Pb(OAc)4,	 	 DCM,	 rt,	 90	min	 (b)	
crude	 aldehyde	 and	 Me2C=CHCH2Br,THF	 added	 to	 Zn	 dust,	
titanocene	 dichloride	 (cat.),	 THF,	 rt,	 16	 h	 (77,	 50:50,	 70%);	 vii,	
TPAP,	NMO,	DCM,	rt,	16	h	(60%).				
	
	 Selective	 removal	 of	 the	 2-(trimethylsilylethoxy)methoxy	
(SEM)	 group	 from	 the	 protected	 hydroxyketone	 78	 gave	 the	
alcohol	 79	 that	 was	 acylated	 to	 give	 the	 butanoyl	 and	
isobutanoyl	 esters	 80	 and	 81.	 Desilylation	 with	 in	 situ	 acetal	
formation	gave	mixtures	of	the	esters	84/86	and	85/87	 formed	
by	 equilibration	 of	 the	 regioisomers	 under	 the	 reaction	
conditions,	 Scheme	 9.	 Selective	 removal	 of	 the	 tert-




spectroscopic	 data.	 The	 hemiacetals	 82-87	 were	 single	
compounds	 (1H	 and	 13C	 NMR)	 with	 their	 configurations	 at	 C2	
assigned	 on	 the	 basis	 of	 the	 anomeric	 effect.	 Spin-decoupling	
and	 2D	 NMR	 methods	 were	 used	 to	 distinguish	 between	 the	
different	regioisomers	(see	experimental).		
	 To	 establish	 the	 effect	 of	 the	 C20	 geminal	 fluorine	
substituents	 on	 the	 PKC	 binding	 and	 biological	 activity	 of	
analogues	 of	 bryostatin,	 it	 was	 decided	 to	 synthesise	 a	
fluorinated	 macrolide	 closely	 related	 to	 a	 non-fluorinated	
compound	 that	 had	 already	 been	 prepared.	 Amongst	 the	
simplest	macrocyclic	compounds	that	are	known	to	show	potent	
PKC	binding	are	the	salicylic	esters	88	prepared	by	Wender.36,37	
It	 was	 therefore	 decided	 to	 prepare	 a	 close	 analogue	 of	 this	








C27	 fragment	 of	 bryostatin	 Reagents	 and	 conditions	 i,	 MgBr2,	
Et2O,	 MeNO2,	 rt,	 2-24	 h	 (79,	 74%;	 83,	 70%);	 ii,	 RCO2H,	 2,4,6-







	 Regioselective	 hydroxylation	 of	 the	 diene	 77	 followed	 by	
oxidative	cleavage	of	the	resulting	vicinal	diol	gave	the	aldehyde	
90.	 Reduction	 using	 sodium	borohydride	 gave	 the	 diol	91	 as	 a	
mixture	 of	 epimers.	 Regioselective	 esterification	 of	 this	 diol	
using	the	protected	salicylic	acid	98	gave	the	ester	92	 that	was	
oxidised	 to	 give	 the	 ketoester	 93.	 Removal	 of	 the	 SEM	 ether	
under	standard	conditions	gave	the	alcohol	94	and	cleavage	of	





of	 the	 salicylate	 under	 the	 reaction	 conditions.	 In	 Wender’s	
syntheses	 of	 the	 macrodiolides	 88,36	 the	 assembly	 of	 the	
macrocycle	was	 carried	 out	 on	 intermediates	 that	 already	 had	
the	C-19	hemiacetal	 functionality	 intact.	 In	our	case,	 the	hemi-
acetal	was	not	present	in	the	seco-acid	95.	This	meant	that	the	
transannular	 hydrogen	 bonding	 found	 in	 bryostatins	 was	 not	
able	to	facilitate	macrocyclisation.	Unfortunately	further	studies	
were	not	possible	and	a	synthesis	of	a	macrocyclic	analogue	of	a	








































































































82 R = SEM
83 R = H
84 R = nPr
85 R = iPr
86 R = nPr




80 R = nPr






























Scheme	 10	 Approaches	 to	 the	 macrodiolide	 89	 Reagents	 and	
conditions	 i,	 (a)	 OsO4,	 NMO,	 tBuOH,	 H2O,	 rt,	 4	 h	 (b)	 Pb(OAc)4,	
Na2CO3,	DCM,	rt,	5	min	(82%	from	77);	ii,	NaBH4,	MeOH,	0	oC,	1	
h	 (83%);	 iii,	 98,	 2,4,6-Cl3C6H2COCl,	 Et3N,	 tol.,	 rt,	 1.5	 h,	 add	91,	
DMAP,	 tol.,	 rt,	 16	 h;	 iv,	 TPAP,	 NMO,	 4Å	 sieves,	 DCM,	 rt,	 16	 h	
(57%	 from	 91);	 v,	 MgBr2,	 MeCN,	 Et2O,	 rt,	 15	 h	 (65%);	 vi,	 Zn,	
PPTS,	 THF,	 reflux,	 30	min;	 vii,	 2,4,6-C6H2COCl,	 py.,	 benzene,	 rt,	
45	 min,	 add	 to	 DMAP,	 benzene,	 60	 oC,	 16	 h;	 viii,	 (a)	 TEMPO,	
PhI(OAc)2,	MeCN,	H2O,	rt,	1	h	(b)	2-methyl-but-2-ene,	NaH2PO4,	





Preliminary	 studies	 were	 next	 carried	 out	 into	 binding	 of	 the	
fluorinated	hemiacetals	83,	84	and	86	 to	purified	PKC	proteins.	
Phorbol	 esters	 and	 bryostatins	 target	 individual	 cysteine-
rich	zinc	finger	motifs	(C1	and	C2	domains)	of	conventional	
and	 novel	 PKCs,	 and	 are	 believed	 to	 lead	 to	 allosteric	
release	 of	 the	 pseudosubstrate	 region.	 Thermal	 profiling	
has	 been	 used	 to	 evaluate	 atypical	 PKC	 isozyme	
destabilisation	 by	 small	 molecules38	 and	 upon	 binding,	
nanomolar	 to	micromolar	 affinity	 kinase	 inhibitors	 usually	
induce	 temperature	 shifts	 in	 the	 range	 of	 2-10	 °C	 in	
vitro.39,40	 In	order	to	analyse	whether	bryostatin	binding	to	
PKC	isozymes	can	also	be	evaluated	in	a	thermal	shift	assay,	
Sypro	 Orange,	 a	 fluorophore	 exhibiting	 enhanced	
fluorescence	when	it	binds	to	unfolded	protein	kinases,40,41	
was	 employed	 for	 real-time	 thermal	 profiling	 with	 three	
affinity-tagged	 purified	 kinases,	 namely	 PKCa,	
representative	 of	 the	 conventional	 PKCs,	 and	 a	 known	
phorbol	 ester	 and	 bryostatin	 target,42	 PKCz,	 an	 ‘atypical’	
PKC	 protein	 that	 lacks	 canonical	 C1	 and	 C2	 domains,	 and	
PKA,	 the	 archetypal	 Ser/Thr	 protein	 kinase	 from	 the	 ‘AGC	





Analysis	 of	 N-terminally	 6His	 affinity-tagged	 human	 PKCa	
(amino	acids	1-672),	human	PKCz	 (amino	acids	2-592)	and	full-
length	 murine	 PKA	 (1-351).	 2	 mg	 of	 the	 indicated	 purified	
proteins	 were	 separated	 by	 SDS-PAGE	 and	 stained	 with	
Coomassie	 Blue.	 The	 positions	 of	 a	 range	 of	 molecular	 mass	
markers	 are	 also	 shown	 (kDa).	 (B)	 Differential	 scanning	
fluorimetry	 reveals	 PKCa	 unfolding	 profiles	 as	 a	 function	 of	
temperature	in	the	presence	of	a	series	of	different	compounds.	
(C)	 PKCz unfolding	 profiles	 evaluated	 as	 a	 function	 of	
temperature	 in	 the	 presence	 of	 the	 indicated	 compounds.	
Thermal	 profiling	 of	 each	 kinase	 in	 the	 presence	 of	 a	 range	of	
concentrations	 of	 pure	 commercial	 bryostatin	 was	 assessed	
using	 purified	 (D)	 PKCa,	 (E)	 PKCz,	 or	 (F)	 PKA	 catalytic	 subunit.	
The	final	concentration	of	each	kinase	 in	the	assays	was	5	µM.	
Triplicate	data	were	 fitted	 to	 the	Boltzmann	Equation,	 and	are	
shown	 for	 duplicate	 experiments.	 DMSO	 was	 the	 control	




them	 suited	 to	 real-time	 thermal	 stability	 studies	 in	 the	
presence	and	absence	of	chemical	compounds.		
	 PKCa underwent	 a	 complex	 unfolding	 transition	 that	 was	
influenced	markedly	 in	 the	 presence	 of	 PMA,	which	 induced	 a	
3°C	 destabilisation	 relative	 to	 control,	 consistent	 with	
polypeptide	domain	structural	reorganisation.	This	destabilising	
effect	was	even	more	marked	with	Ca2+	 ions,	 leading	to	a	>6°C	
change	 in	 thermal	 stability	 relative	 to	 control.	 In	 contrast,	 the	
broad	PKC	ATP-binding	 site	 inhibitor	 staurosporine44	promoted	
an	expected	PKCa	stabilisation,	consistent	with	interaction	with	
the	 nucleotide-binding	 (ATP)	 site.	 Based	 on	 thermal	 profiling,	
little	 or	 no	 destabilisation	 by	 PMA	 was	 detected	 for	 PKCz,	
consistent	with	 absence	 of	 a	 C2	 domain.	 In	 contrast,	 Ca2+	 ions	
markedly	 destabilised	 PKCz,	 which	 possesses	 an	 atypical	 Ca2+-
binding	 C1	 domain,	 and	 staurosporine	 induced	 a	 +9°C	
stabilisation,	 in	 line	 with	 its	 reported	 nanomolar	 potency	
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Fig.	 10.	 PKC	 Thermal	 shift	 analysis	 of	 fluorinated	 bryostatins.	
Real-time	thermal	stability	assay	for	each	kinase	was	performed	
in	 the	presence	and	absence	of	 the	 indicated	 concentration	of	
bryostatin	 analogues	 83	 (A-C),	 84	 (D-F)	 or	 86	 (G-I).	 The	 final	
concentration	 of	 each	 purified	 protein	 kinase	 was	 5	 µM.	
Triplicate	data	were	 fitted	 to	 the	Boltzmann	Equation,	 and	are	
shown	 for	 duplicate	 experiments.	 DMSO	 was	 the	 control	
solvent,	and	PMA	was	the	positive	control	compound	for	PKCa.	
Similar	results	were	seen	in	independent	experiments.		
evaluated	 the	 effects	 of	 compounds	 83,	 84	 and	 86	 on	
temperature-dependent	 PKC	 unfolding.	 As	 detailed	 in	 Fig.	 10,	
83had	 a	 very	 subtle	 destabilising	 effect	 on	 PKCa,	 but	 was	
without	effect	on	PKCz or	PKA,	suggestive	of	a	weak	interaction.	
In	marked	contrast,	86	induced	a	complex,	but	dose-dependent	
bryostatin-like	 destabilisation	 of	 PKCa,	 but	 not	 PKCz	 or	 PKA,	
suggesting	 direct	 binding	 to	 a	 biologically	 relevant	 PKCa	
conformation.	 No	 effects	 of	 84	 were	 noted	 on	 PKCa,	 PKCz	 or	
PKA,	even	at	40-fold	molar	excess	compounds.	Together,	these	
data	 establish	 a	 new	 semi-quantitative	 assay	 for	 rapidly	
evaluating	binding	of	bryostatins	to	PKC	isozymes,	and	raise	the	
likelihood	that	fluorinated	compounds	such	as	86	might	possess	
biological	 PKCa	 regulatory	 activity.	 Testing	 this	 hypothesis	will	
be	 the	 focus	of	 future	experiments,	which	will	 include	enzyme	




This	 paper	 reports	 the	 synthesis	 and	 preliminary	 PKC	 binding	




represent	 modified	 C17-C27	 fragments	 that	 had	 not	 been	
evaluated	 previously.	 It	 was	 hoped	 that	 the	 two	 electron-
withdrawing	fluorine	substituents	at	C20	(bryostatin	numbering)	
would	 stabilise	 the	 ring-closed,	 hemi-acetal	 tautomers	 and	
inhibit	any	dehydration	involving	the	crucial	C19	hydroxyl	group.	
It	 was	 recognised	 that	 the	 fluorine	 substituents	 would	 also	
increase	 the	 acidity	 of	 the	 C19	 hydroxyl	 group	 by	 about	 three	
pKa	 units	 and	 make	 the	 C21	 methylene	 substituent	 more	
electrophilic.			
	 In	 the	 event,	 the	 fluorine	 containing	 hemi-acetals	 82	 –	 87	
were	prepared	 in	 ca.	 10	 steps	 from	 the	 known	alkene	71.	 The	
key	 steps	 in	 these	 syntheses	were	 the	 difluoroallylation	of	 the	
aldehyde	 72	 and	 the	 (E)-selective	 Wittig	 reaction	 of	 the	 a,a-
difluorinated	 ketone	74.	 	 During	 the	 course	 of	 the	work	 other	
approaches	 were	 evaluated	 including	 the	 difluoroallylation	




	 The	 binding	 of	 the	 fluorinated	 compounds	 83,	 84	 and	 86	
with	 purified	 human	 PKCa	 were	 studied	 and	 very	 promising	
early	 data	 obtained	 based	 on	 comparative	 profiling	 with	
authentic	bryostatin	1.	It	is	hoped	that	this	work	will	encourage	
other	 research	 workers	 to	 develop	 further	 analogues	 of	






	 Flash	 column	 chromatography	was	 performed	 using	Merck	
silica	gel	(60H,	230-300	mesh).	Base	washed	siica	was	prepared	
by	 stirring	 silica	 in	 saturated	 aqueous	 potassium	 hydrogen	
carbonate	 for	 24	h	 then	 rinsing	with	deionised	water	until	 the	
washings	were	pH	7,	followed	by	rigorous	drying	in	an	oven.		
	 Light	 petroleum	 refers	 to	 the	 fraction	 boiling	 between	 40	
and	 60	 °C	 and	was	 redistilled.	 Tetrahydrofuran	was	 dried	 over	
sodium-benzophenone	 and	 was	 distilled	 under	 nitrogen.	




ionisation	 using	 ammonia	 (CI+),	 electrospray	 ionisation	 in	 the	
positive	mode	(ES+),	atmospheric	pressure	chemical	ionisation	in	
the	 positive	 mode	 (APCI+)	 and	 time	 of	 flight	 MS	 with	
electrospray	 ionisation	 (TOF	 ES+).	 Low	 resolution	mass	 spectra	
were	recorded	on	a	Waters	SQD2	or	on	an	Agilent	5975C	Triple	
axis	spectrometer.	High	resolution	mass	spectra	were	recorded	
using	 a	 Thermo	 Finnigan	 MAT95XP	 or	 on	 a	 Waters	 QTOF	
spectrometer.	 Infra-red	 spectra	were	measured	using	 a	 Bruker	
Alpha	 P	 FTIR	 spectrometer	 on	 NaBr	 plates,	 either	 neat	 or	 as	
evaporated	 films.	 Nuclear	 magnetic	 resonance	 spectra	 were	
recorded	using	Bruker	Avance	300,	Bruker	Ultrashield	400	or	on	
Bruker	 Ultrashield	 500	 spectrometers	 at	 ca.	 25	 oC	 unless	
otherwise	stated.	Coupling	constants	 (J)	are	given	 in	Hertz	 (Hz)	
and	 chemical	 shifts	 are	 relative	 to	 tetramethylsilane.	 Residual	
non-deuteriated	solvent	was	used	as	the	internal	standard.		
	 Differential	scanning	fluorimetry	(DSF)	was	performed	with	a	
StepOnePlus	 Real-Time	 PCR	 machine	 (Life	 Technologies)	 using	
Sypro-Orange	 dye	 (Invitrogen)	 and	 thermal	 ramping	 (0.3	 °C	 in	
step	 intervals	between	25	and	94°C).	PKA	catalytic	subunit	was	
PKA
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purified	 as	 described	 previously.41	 Purified	 PKC	 proteins	 were	
purchased	 from	MRC-PPU	Reagents	and	Services	 (University	of	
Dundee),	and	were	diluted	to	a	final	concentration	of	5	μM	in	50	
mM	 Tris/HCl,	 pH	 7.4	 and	 100	 mM	 NaCl	 in	 the	 presence	 or	
absence	 of	 the	 indicated	 concentrations	 of	 ligand	 (final	 DMSO	
concentration	was	never	higher	than	4	%	v/v).	Normalized	data	
were	 processed	 using	 the	 Boltzmann	 equation	 to	 generate	
sigmoidal	 denaturation	 curves,	 and	 these	 were	 plotted	 as	
previously	 described.44	 Staurosporine	 (S-9300),	 bryostatin	 1	
(B6697)	 and	 phorbol	 12-myristate	 13-acetate	 (PMA,	 P-1680)	
were	 all	 purchased	 from	 LC	 Laboratories	 and	 dissolved	 and	
diluted	in	DMSO	prior	to	use.		
3-(Benzothiazol-2-ylsulfanyl)-2,2-dimethylpropanal	 (8).	
Triphenylphosphine	 (18	 g,	 68	 mmol)	 and	 2-
mercaptobenzothiazole	 (11.4	 g,	 68	 mmol)	 was	 added	 to	
neopentyl	 glycol	 (10	 g,	 96	 mmol)	 in	 THF	 (150	 mL)	 and	 the	
solution	cooled	to	0	°C.	Di-isopropyl	azodicarboxylate	(13.4	mL)	
in	THF	(200	mL)	was	added	dropwise	over	1	h	and	the	solution	
stirred	 at	 0	 °C	 for	 2	 h	 and	 at	 rt	 for	 16	 h.	Water	 (200	mL)	was	
added	 followed	by	EtOAc	 (200	mL)	and	 the	aqueous	 layer	was	
extracted	with	 EtOAc	 (3	×	 100	mL).	 The	 organic	 extracts	were	
washed	with	aqueous	NaOH	(1	M,	100	mL)	and	brine	(100	mL),	
dried	 (MgSO4)	 and	 concentrated	 under	 reduced	 pressure.	
Chromatography	 of	 the	 residue	 (90:10	 light	 petroleum:EtOAc)	
gave	3-(benzothiazol-2-ylsulfanyl)-2,2-dimethylpropanol	(14.5	g,	
84	%)	as	a	colourless	oil,	Rf	=	0.8	(EtOAc)	(Found:	Found:	M+	+	











mixture	 stirred	until	 gas	 evolution	 stopped.	 The	 aqueous	 layer	
was	 extracted	with	 DCM	 (3	 ×	 20	mL)	 and	 the	 organic	 extracts	
were	dried	(MgSO4)	and	concentrated	under	reduced	pressure.	
Chromatography	 of	 the	 residue	 (75:25	 light	 petroleum:EtOAc)	
gave	the	title	compound	8	 (0.8	g,	81	%)	as	a	yellow	oil,	Rf	=	0.9	
(EtOAc)	 (Found:	 M+	 +	 H,	 252.0516.	 C12H14NOS2	 	 requires	 M,	
252.0512);	nmax/cm-1	2976,	1774,	1726,	1460,	1428,	1241,	1095,	
1017	and	757;	δH	(400	MHz,	CDCl3)	1.18	(6	H,	s,	2	×	2-CH3),	3.58	










16	 h.	 Water	 (20	 mL)	 was	 added	 and	 the	 aqueous	 layer	 was	
extracted	 with	 DCM	 (3	 ×	 20	 mL).	 The	 organic	 extracts	 were	
dried	 (MgSO4)	 and	 concentrated	 under	 reduced	 pressure.	







H,	 s,	OCH2O)	 and	7.34-7.37	 (5	H,	m,	ArH);	 δC	 (125	MHz,	CDCl3)	
21.9,	 36.1,	 69.6,	 71.1,	 76.5,	 91.6,	 127.8,	 128.5	 and	 137.6;	m/z	
(ES+)	247	(M+	+	23,	100%).	
	 Molecular	 sieves	 (7.0	g),	NMO	 (1.65	g,	14	mmol)	and	TPAP	
(82	mg,	0.23	mmol)	were	added	to	this	alcohol	(2.1	g,	9.4	mmol)	
in	DCM	(20	mL)	and	acetonitrile	(5	mL)	and	the	mixture	stirred	
at	 rt	 for	 2	h	 and	 then	 filtered	 through	a	pad	of	 silica	 that	was	
washed	 with	 DCM	 (3	 ×	 30	 mL)	 and	 EtOAc	 (3	 ×	 30	 mL).	 The	
filtrate	 and	 washings	 were	 concentrated	 under	 reduced	
pressure	 and	 chromatography	 of	 the	 residue	 the	 gave	 title	




OCH2O),	7.31-7.36	 (5	H,	m,	ArH)	and	9.56	 (1	H,	 s,	1-H);	δC	 (100	





14	mmol)	 and	 copper(I)	 chloride	 (cat.)	were	 added	 to	 THF	 (10	
mL)	under	nitrogen	and	the	suspension	stirred	at	rt	for	30	min.	
Ethyl	 bromodifluoroacetate	 11	 (1.3	 mL,	 10	 mmol)	 was	 added	
followed,	 after	 10	 min,	 by	 3-(2-benzothiazolyl)sulfanyl-2,2-
dimethylpropanal	8	(1.7	g,	6.8	mmol)	in	THF	(5	mL).	The	mixture	
was	stirred	under	 reflux	 for	16	h	 then	cooled	 to	 rt	and	diluted	
with	EtOAc	(20	mL).	The	black	suspension	was	filtered	through	a	
plug	 of	 silica	 that	 was	 washed	 with	 ether	 (4	 ×	 40	 mL).	 The	
filtrate	 was	 concentrated	 under	 reduced	 pressure	 and	
chromatography	 of	 the	 residue	 (80:20	 light	 petroleum:ether)	
gave	 the	 title	 compound	12	 (2.11	 g,	 83%)	 as	 a	 yellow	 oil,	Rf	 =	
0.55	 (70:30	 light	 petroleum:EtOAc)	 (Found:	M+	 +	 H,	 376.0843.	
C16H20NO3F2S2	 requires	 M,	 376.0848);	 nmax/cm-1	 3182,	 2956,	
1775,	 1459,	 1428,	 1307,	 1074,	 1004	 and	 756;	 δH	 (400	 MHz,	




7.68-7.63	 (2	 H,	m,	 ArH);	 δC	 (100	MHz,	 CDCl3)	 13.7,	 18.8,	 19.5,	
36.1,	46.4,	62.5,	71.4	(t,	2JC-F	22),	117.5	(t,	1JC-F	251),	120.5,	121.2,	






the	 synthesis	 of	 the	 hydroxyester	 12,	 zinc	 powder	 (60	mg,	 0.9	






9	 (0.1	 g,	 0.45	 mmol),	 after	 heating	 under	 reflux	 for	 36	 h	 and	
chromatography	 (85:15	 light	 petroleum:EtOAc),	 gave	 the	 title	
compound	13	 (0.12	 g,	 75%)	 as	 a	 colourless	 oil,	Rf	 =	 0.6	 (70:30	
light	 petroleum:EtOAc)	 (Found:	 M+	 +	 Na,	 369.1483.	
C17H24O5F2Na	 requires	 M,	 369.1485);	 nmax/cm-1	 3458,	 2942,	
2884,	1759,	1455,	1308,	1045,	910	and	740;	δH	(500	MHz,	CDCl3)	
1.09	and	1.22	(each	3	H,	s,	4-CH3),	1.37	(3	H,	t,	J	7.5,	OCH2CH3),	









4,4-dimethylpentanoate	 (14).	 The	 procedure	 outlined	 for	 the	
synthesis	of	the	hydroxyester	12	using	zinc	powder	(0.61	g,	9.4	
mmol),	 copper(I)	 chloride,	 ethyl	 bromodifluoroacetate	 11	 (0.8	
mL,	 6.1	 mmol)	 and	 3-tert-butyldiphenylsilyloxy-2,2-
dimethylpropanal	 10	 (1.6	 g,	 4.7	 mmol),	 after	 heating	 under	
reflux	for	36	h,	an	aqueous	extraction	using	ether	(15	mL),	water	
(10	mL)	and	aqueous	hydrogen	chloride	(1	M,	10	mL),	and	with	
extraction	of	 the	 aqueous	 layer	 using	 ether	 (3	 ×	 15	mL),	 gave,	
after	 chromatography	 (90:10	 light	 petroleum:EtOAc),	 the	 title	
compound	14	(0.7	g,	78%)	as	a	colourless	oil,	Rf	=	0.7	(70:30	light	












dimethyl-3-triethylsilyloxypentanoate	 (15).	 2,6-Lutidine	 (1.3	
mL,	11	mmol)	and	 triethylsilyl	 triflate	 (1.9	mL,	8.4	mmol)	were	
added	to	the	hydroxyester	12	(2.1	g,	5.6	mmol)	in	DCM	(20	mL)	
at	0	°C	and	the	mixture	stirred	at	rt	for	24	h.	Water	(20	mL)	was	



















triethylsilyloxypentanoate	 (16).	 Following	 the	 procedure	
outlined	 for	 the	 preparation	 of	 the	 silyl	 ether	 15,	 the	
hydroxyester	 13	 (0.2	 g,	 0.58	 mmol),	 2,6-lutidine	 (0.2	 mL,	 1.7	
mmol)	and	triethylsilyl	triflate	(0.2	mL,	0.87	mmol)	with	stirring	
for	 10	 d,	 after	 chromatography	 (85:15	 light	 petroleum:EtOAc)	
gave	the	title	compound	16	(0.24	g,	85%)	as	a	colourless	oil,	Rf	=	
0.75	(70:30	 light	petroleum:EtOAc)	 (Found:	M+	+	Na,	483.2337.	






5.0,	OHCHO)	and	7.32-7.37	 (5	H,	m,	ArH);	 δC	 (100	MHz,	CDCl3)	
5.1,	6.8,	13.8,	18.0,	20.5,	21.2,	38.9,	62.7,	69.3,	74.7,	75.1,	94.7,	





dimethyl-3-triethylsilyloxypentanoate	 (17).	 Following	 the	
procedure	outlined	for	the	preparation	of	the	silyl	ether	15,	the	
hydroxyester	 14	 (0.2	 g,	 0.43	mmol),	 2,6-lutidine	 (0.12	mL,	 1.0	
mmol)	and	triethylsilyl	triflate	(0.2	mL,	0.86	mmol)	with	stirring	

















extracts	 were	 dried	 (MgSO4)	 and	 concentrated	 under	 reduced	
pressure.	 Chromatography	 of	 the	 residue	 (90:10	 light	
petroleum:EtOAc)	gave	the	title	compound	18	(0.93	g,	77%)	as	a	
yellow	oil,	Rf	 =	0.7	 (70:30	 light	petroleum:EtOAc)	 (Found:	M+	+	





7.67	 (1	 H,	 d,	 J	 7.8,	 ArH)	 and	 7.77	 (1	 H,	 d,	 J	 8.0,	 ArH);	 δC	 (100	






(d,	 2JC-F	30);	δF	 (376	MHz,	CDCl3)	-110.73	and	-107.56	 (each	d,	
2JF-F	270.7);	m/z	(ES+)	482	(M+	+	23,	100%)	and	460	(M+	+	1,	55).	
	 Methyllithium	(1.0	M,	0.07	mL,	0.7	mmol)	was	added	to	the	
ester	 15	 (0.13	 g,	 0.27	 mmol)	 in	 THF	 (2	 mL)	 at	 0	 °C	 and	 the	




the	 residue	 (80:20	 light	 petroleum:ether)	 gave	 6-(2-
benzothiazolyl)sulfanyl-3,3-difluoro-4-triethylsilyloxy-2,5,5-
trimethylhexan-2-ol	 (86	 mg,	 72%)	 as	 a	 colourless	 oil,	 Rf	 =	 0.5	
(70:30	 light	 petroleum:EtOAc)	 (Found:	 M+	 +	 H,	 476.1922.	
C22H36NO2F2S2Si	 requires	 M,	 476.1920);	 nmax/cm-1	 3452,	 2954,	
1536,	 1458,	 1428,	 1238,	 1159,	 1070,	 1003	 and	 740;	 δH	 (500	
MHz,	CDCl3)	0.44-0.46	(6	H,	m,	3	×	SiCH2),	0.74	(9	H,	t,	J	10.0,	3	×	
CH2CH3),	1.14	and	1.19	(each	3	H,	s,	5-CH3),	1.28	and	1.31	(each	







triethylsilyloxyhexan-2-one	 (19).	 Following	 the	 procedure	
outlined	for	the	synthesis	of	the	ketone	18,	the	ester	16	(50	mg,	
0.11	mmol)	 in	 THF	 (2	mL)	 and	methyllithium	 (1.0	M,	 0.16	mL,	
0.16	 mmol),	 after	 chromatography	 (90:10	 light	 petroleum:	
EtOAc)	gave	the	title	compound	19	(44	mg,	86%)	as	a	yellow	oil,	
Rf	 =	 0.7	 (70:30	 light	 petroleum:EtOAc)	 (Found:	 M+	 +	 Na,	
453.2245.	C22H36O4F2SiNa	requires	M,	453.2244);	nmax/cm-1	2993,	












triethylsilyloxyhexan-2-one	 (20).	 Following	 the	 procedure	
outlined	for	the	synthesis	of	the	ketone	18,	the	ester	17	(0.5	g,	
0.8	mmol)	in	THF	(20	mL)	and	methyllithium	(1.0	M,	1.3	mL,	1.3	
mmol),	 after	 chromatography	 (90:10	 light	 petroleum:	 EtOAc)	
gave	the	title	compound	20	(0.22	g,	55%)	as	a	colourless	oil,	Rf	=	
0.8	 (70:30	 light	petroleum:EtOAc)	 (Found:	M+	+	Na,	 	 571.2854.	
C30H46O3F2Si2Na	 requires	 M,	 571.2846);	 nmax/cm-1	 2980,	 1724,	
1423,	1201	and	1109;	δH	(500	MHz,	CDCl3)	0.55-0.65	(6	H,	m,	3	×	
SiCH2),	0.92	(9	H,	t,	J	6.0,	3	×	SiCH2CH3),	1.09	(3	H,	s,	5-CH3),	1.12	
[9	H,	 s,	 SiC(CH3)3],	1.28	 (3	H,	 s,	5-CH3),	2.34	 (3	H,	 s,	1-H3),	3.35	
and	3.48	(each	1	H,	d,	J	10.0,	6-H),	4.35	(1	H,	t,	J	10.0,	4-H),	7.37-
7.44	 (6	 H,	m,	 ArH)	 and	 7.66-7.68	 (4	 H,	m,	 ArH);	 δC	 (100	MHz,	
CDCl3)	 6.5,	 6.9,	 19.2,	 19.4,	 20.9,	 26.2,	 26.9,	 40.1,	 70.0,	 74.3	 (t,	





in	 THF,	 0.5	 mL,	 0.5	 mmol)	 was	 added	 to	
methyl(triphenyl)phosphonium	 bromide	 (0.2	 g,	 0.56	 mmol)	 in	
toluene	(2	mL)	at	0	 °C	and	the	solution	was	stirred	 for	30	min.	
The	ketone	19	(80	mg,	0.19	mmol)	in	toluene	(1	mL)	was	added	
and	 the	mixture	 was	 stirred	 at	 rt	 for	 48	 h.	Water	 (2	mL)	 was	
added	 followed	 by	 EtOAc	 (5	 mL)	 and	 the	 aqueous	 phase	 was	
extracted	with	EtOAc	(3	×	5	mL).	The	organic	extracts	were	dried	
(MgSO4)	 and	 concentrated	 under	 reduced	 pressure.	
Chromatography	 of	 the	 residue	 (90:10	 light	 petroleum:ether)	
gave	the	title	compound	21	(60	mg,	75%)	as	a	colourless	oil,	Rf	=	
0.9	 (70:30	 light	 petroleum:EtOAc)	 (Found:	M+	 +	 Na,	 451.2458.	














2,5,5-trimethylhex-1-ene	 (22).	 Following	 the	 procedure	
outlined	 for	 the	 synthesis	 of	 the	 alkene	 21,	
methyl(triphenyl)phosphonium	bromide	 (0.16	 g,	 0.45	mmol)	 in	
toluene	 (2	mL),	 potassium	hexamethyldisilazide	 (1.0	M	 in	 THF,	
0.41	mL,	0.41	mmol)	and	the	ketone	20	 (84	mg,	0.15	mmol)	 in	

















Bromosuccinimide	 (12	 mg,	 0.065	 mmol)	 was	 added	 to	 the	
alkene	 22	 (30	 mg,	 0.055	 mmol)	 in	 chloroform	 	 (1	 mL).	 The	
suspension	was	exposed	to	UV	light	for	10	min	and	then	heated	
under	 reflux	 for	 24	 h.	 After	 cooling	 to	 rt,	 the	 mixture	 was	





residue	 (90:10	 light	petroleum:EtOAc)	gave	 the	 title	 compound		
23	 (25	 mg,	 72%)	 as	 a	 colourless	 oil,	 Rf	 =	 0.9	 (70:30	 light	
petroleum:EtOAc)	 (Found:	 M+	 +	 Na,	 647.2169.	
C31H47O279BrF2Si2Na	 requires	 M,	 647.2159;	 Found:	 M+	 +	 Na,	












2.0	mmol)	were	 added	 to	 sodium	 iodide	 (0.62	 g,	 4.0	mmol)	 in	




10	 mL).	 The	 organic	 extracts	 were	 dried	 (MgSO4)	 and	
concentrated	 under	 reduced	 pressure.	 Chromatography	 of	 the	
residue	(light	petroleum	to	90:10	light	petroleum:EtOAc)	gave	5-
iodohex-5-en-3-ol	28	 (0.33	g,	80%)	as	a	colourless	oil,	Rf	=	0.55	






	 Imidazole	 (0.21	 g,	 3.1	 mmol)	 and	 tert-butyldimethylsilyl	
chloride	 (0.26	g,	1.7	mmol)	were	added	 to	5-iodohex-5-en-3-ol	
28	(0.32	g,	1.4	mmol)	in	DCM	(10	mL)	and	the	solution	stirred	at	
rt	 for	 24	 h.	Water	 (10	mL)	was	 added,	 the	 aqueous	 layer	was	
extracted	with	DCM	(3	×	10	mL)	and	the	organic	extracts	were	
dried	 (MgSO4)	 and	 concentrated	 under	 reduced	 pressure.	












was	 added	 to	 a	 vigorously	 stirred	 solution	 of	 ethyl	 2-iodo-2,2-
difluoroacetate	25	(0.025	mL,	0.170	mmol)	in	anhydrous	DMSO	
(0.20	mL).	After	3	h,	the	alkenyl	iodide	29	(19	mg,	0.057	mmol)	
in	 anhydrous	 DMSO	 (0.20	 mL)	 was	 added	 and	 the	 mixture	
stirred	 1.25	 h.	 A	 mixture	 of	 ice	 and	 saturated	 aqueous	
ammonium	chloride	 (1:1,	10	mL)	was	added	 followed	by	ether	
(10	mL).	 The	 aqueous	 phase	was	 extracted	with	 ether	 (3	 ×	 10	
mL)	and	the	organic	extracts	were	filtered	through	Celite®	using	
ether	(20	mL).	The	filtrate	was	washed	with	brine	(50	mL),	dried	
(MgSO4)	 and	 concentrated	 under	 reduced	 pressure.	
Chromatography	 of	 the	 residue	 using	 base-washed	 silica	
(0.5:99.5	to	1:99	ether:light	petroleum)	gave	the	title	compound	
30	 (8	mg,	 0.024	mmol,	 8%)	 as	 a	 colourless	 oil,	Rf	 =	 0.27	 (1:99	







CDCl3)	 -4.6,	 -4.5,	 9.2,	 13.9,	 18.0,	 25.9,	 29.4,	 37.7,	 63.0,	 71.5,	
114.0	 (t,	 1JC-F	 252.1),	 120.5	 (t,	 3JC-F	 8.2),	 137.7	 (t,	 2JC-F	 22.8)	 and	
163.9	 (t,	 2JC-F	 34.6);	 δF	 (471	MHz,	 CDCl3)	-106.99	 and	-105.25	
(both	 d,	 JF-F	 253.4);	m/e	 (ES+)	 359.2	 (M+	 +	 23,	 50%)	 and	 210.2	
(100).	This	capricious	reaction	required	copper	powder	that	was	
very	 fine,	 bronze-pink	 in	 colour	 and	 extremely	 lustrous,	
anhydrous	solvent	and	vigorous	stirring,	 to	generate	 the	active	
copper-reagent	species.		






and	0.91	 [each	9	H,	 s,	 SiC(CH3)3],	 1.34	 (3	H,	 t,	 J	7.3,	OCH2CH3),	
4.29	(2	H,	s,	3-CH2),	4.29	(2	H,	q,	J	7.3,	OCH2CH3),	4.39-4.42	(2	H,	
m,	5-H2)	and	6.39	(1	H,	t,	 J	6.3,	4-H);	δC	(100	MHz,	CDCl3)	-5.7,	
-5.3,	 13.9,	 18.3(2),	 25.8,	 25.9,	 57.4,	 59.7,	 62.7,	 113.0	 (t,	 1JC-F	
251.1),	130.6	 (t,	 2JC-F	21.4),	135.6	 (t,	 3JC-F	 	8.8)	and	163.6	 (t,	 2JC-F	
34.6);	 δF	 (377	MHz,	 CDCl3)	-106.47;	m/z	 (ES+)	 461.3	 (M+	 +	 23,	
100%).	
	 This	 procedure	 gave	 ethyl	 (E)-2,2-difluoro-5-tert-
butyldiphenylsilyloxy-3-(tert-butyldiphenylsilyloxymethyl)pent-
3-enoate	34	 (4	mg,	 0.006	mmol,	 14%)	 as	 a	 colourless	 oil,	Rf	 =	













(4.40	mL)	was	added	and	 the	mixture	 stirred	 for	5	h.	Aqueous	
hydrogen	chloride	(10%,	50	mL)	and	EtOAc	(50	mL)	were	added	
and	 the	aqueous	phase	was	extracted	with	EtOAc	 (3	×	50	mL).	
The	 organic	 extracts	 were	 washed	 with	 brine	 (200	 mL),	 dried	
(MgSO4)	 and	 concentrated	 under	 reduced	 pressure.	
Chromatography	 of	 the	 residue	 (10:90	 ether:light	 petroleum)	





















(0.2	 g,	 1.74	 mmol)	 and	 lithium	 iodide	 (0.23	 g,	 1.74	 mmol)	 in	
deionised	water	 (3.46	mL)	 and	 the	mixture	 stirred	 for	 10	min.	
The	 aldehyde	 39	 (0.27	 g,	 0.867	 mmol)	 in	 THF	 (1.73	 mL)	 was	
added	 and	 the	 reaction	 mixture	 stirred	 for	 72	 h.	 Aqueous	
hydrogen	chloride	(10%,	30	mL)	and	EtOAc	(10	mL)	were	added	
and	 the	aqueous	phase	was	extracted	with	EtOAc	 (3	×	30	mL).	
The	 organic	 extracts	 were	 washed	 with	 brine	 (100	 mL),	 dried	
(Na2SO4)	 and	 concentrated	 under	 reduced	 pressure	 to	 give	 a	
yellow	 oil	 (0.375	 g)	 that	 was	 azeotroped	with	 benzene	 before	
being	taken	into	DCM	(6.0	mL).	 Imidazole	(0.142	g,	2.08	mmol)	
and	 tert-butyldiphenylsilyl	 chloride	 (0.27	mL,	 1.04	mmol)	were	
added	at	0	oC	and	the	reaction	mixture	was	stirred	at	rt	for	48	h.	
Saturated	 aqueous	 ammonium	 chloride	 (30	mL)	 and	 DCM	 (30	
mL)	were	added	and	the	aqueous	phase	was	extracted	into	DCM	
(3	×	30	mL).	The	organic	extracts	were	washed	with	brine	(120	
mL),	 dried	 (MgSO4)	 and	 concentrated	 under	 reduced	pressure.	
Chromatography	 of	 the	 residue	 (1:99	 ether:light	 petroleum)	








and	 7.45-7.51	 and	 7.61-7.66	 (each	 4	H,	m,	 ArH);	 δC	 (100	MHz,	
CDCl3)	 18.7,	 19.3,	 26.4,	 26.6,	 35.1,	 59.9,	 71.8	 (dd,	 2JC-F	 32.4,	
26.9),	 119.9	 (t,	 1JC-F	 244.6),	 120.4	 (t,	 3JC-F	 9.3),	 127.2(2),	 129.1,	







dry	 DCM	 (6.55	 mL)	 at	 -78	 °C	 for	 5	 min	 until	 a	 blue	 colour	
persisted.	 The	 system	 was	 purged	 with	 oxygen	 for	 10	 min,	
dimethyl	 sulfide	 (0.20	 mL,	 2.72	 mmol)	 was	 added	 and	 the	
mixture	 was	 stirred	 at	 rt	 for	 3.5	 h.	 After	 concentration	 under	
reduced	pressure,	 the	 residue	was	dissolved	 in	 tBuOH	 (9.5	mL)	
and	 2-methylbut-2-ene	 (2	 M	 in	 THF,	 0.63	 mL)	 was	 added	
followed	by	a	 solution	of	 sodium	chlorite	 (0.295	g,	3.26	mmol)	
and	Na2H2PO4.2H2O	(0.85	g,	5.44	mmol)	 in	distilled	water	 (4.85	







mmol)	 was	 added	 dropwise	 before	 stirring	 for	 48	 h.	 After	
concentration	under	 reduced	pressure,	 chromatography	of	 the	
residue	 (0.5:99.5	 to	 1:99	 ether:light	 petroleum)	 gave	 the	 title	
compound	42	(0.29	g,	0.436	mmol,	80%)	as	a	colourless	oil,	Rf	=	
0.40	(10:90	ether:light	petroleum)	(Found:	M+	+	NH4,	678.3253.	





and	 7.45-7.50	 and	 7.61-7.68	 (each	 4	H,	m,	 ArH);	 δC	 (125	MHz,	
CDCl3)	 19.0,	 19.4,	 26.7(2),	 34.5,	 53.0,	 59.8,	 70.7	 (t,	 2JC-F	 25.5),	
115.2	(t,	1JC-F	253.9),	127.5,	127.7,	129.5(2),	129.8,	129.9,	132.1,	
133.1,	 133.6(2),	 135.4,	 135.5,	 135.8,	 136.0	 and	 164.0	 (t,	 2JC-F	






0.112	 mmol)	 in	 dry	 THF	 (2.2	 mL)	 at	 -78	 °C	 and	 the	 solution	
stirred	 at	 -78	 °C	 for	 5	 h.	 Saturated	 methanolic	 ammonium	
chloride	 (5	 mL)	 was	 added	 at	 -78	 °C	 and	 the	 mixture	 was	
allowed	 to	warm	 to	 rt.	Water	 (10	mL)	 and	DCM	 (10	mL)	were	
added	and	the	aqueous	phase	was	extracted	with	DCM	(3	×	10	
mL).	The	organic	extracts	were	washed	with	brine	(40	mL),	dried	
(MgSO4)	 and	 concentrated	 under	 reduced	 pressure.	
Chromatograpy	 of	 the	 residue	 (0.5:99.5	 ether:light	 petroleum)	




822	 and	 739;	 δH	 (400	MHz,	 CDCl3)	 0.93	 and	 0.99	 [each	 9	H,	 s,	
SiC(CH3)3],	1.21	 [9	H,	s,	C(CH3)3],	1.72-1.87	 (2	H,	m,	6-H2),	3.43-
3.49	(2	H,	m,	7-H2),	4.54	(1	H,	m,	5-H),	7.28-7.43	(12	H,	m,	ArH)	
and	 7.43-7.50	 and	 7.66-7.71	 (each	 4	H,	m,	 ArH);	 δC	 (100	MHz,	
CDCl3)	19.0,	19.6,	25.9,	26.7,	26.8,	34.3,	43.7,	60.0,	69.7	(t,	2JC-F	
25.8),	 118.2	 (t,	 1JC-F	 261.7),	 127.5,	 127.6,	 129.4,	 129.5,	 129.7,	
129.8,	132.2,	133.5,	133.6,	133.7,	135.4,	135.5,	135.9,	136.0	and	





fluoride	 (1	M	 in	 THF,	 0.70	mL,	 0.704	mmol)	was	 added	 to	 the	
ketone	43	(0.23	g,	0.335	mmol)	in	THF	(3.35	mL)	at	0	°C	and	the	
solution	 stirred	 at	 rt	 for	 15	 h.	 Saturated	 aqueous	 ammonium	
chloride	(10	mL),	water	(10	mL)	and	EtOAc	(20	mL)	were	added	





The	 organic	 extracts	 were	 washed	 with	 brine	 (60	 mL),	 dried	
(MgSO4)	 and	 concentrated	 under	 reduced	 pressure.	
Chromatography	of	the	residue	(10:90	ether:light	petroleum	to	




51.40;	 H,	 7.70%;	 Found:	 M+	 +	 Na,	 233.0956.	 C9H16O3F2Na	
requires	M,	233.0965);	nmax/cm-1	3434,	2965,	2941,	1338,	1093,	




4-H);	 δC	 (100	MHz,	 benzene-d6)	 26.2	 (t,	 4JC-F	 3.6),	 32.3	 (d,	 3JC-F	
5.8),	40.0	 (t,	 3JC-F	2.9),	58.7,	68.0	 (dd,	 2JC-F	22.6,	21.1),	99.7	 (dd,	
2JC-F	 29.9,	24.1)	and	121.3	 (dd,	 1JC-F	 258.0,	251.4);	δF	 (377	MHz,	
benzene-d6)	-130.11	(d,	2JF-F	240.0)	and	-118.89	(d,	2JF-F	238.7);	
m/z	(ES-)	209	([M-H]-,	100%);	(ES+)	233.1	(M+	+	23,	100%).	
	 After	 standing	 in	 solution	 in	 benzene-d6	 for	 48	 h,	 the	






100.5	 (dd,	 2JC-F	 26.2,	 24.8)	 and	117.6	 (dd,	 1JC-F	 260.2,	 253.7);	 δF	
(377	MHz,	benzene-d6)	 115.73	 (d,	 2JF-F	252.3)	and	 113.93	 (d,	





chloride	 (0.31	 M	 in	 THF,	 1.22	 mL,	 0.38	 mmol)	 was	 added	
dropwise	 to	 the	methyl	 ester	42	 (0.167	 g,	 0.253	mmol)	 in	 dry	
THF	(2.7	mL)	at	-10	°C	and	the	solution	stirred	at	-10	°C	for	12	
h.	 Saturated	 methanolic	 ammonium	 chloride	 (2.5	 mL)	 was	
added	 at	-10	 °C	 and	 the	mixture	 was	 allowed	 to	 warm	 to	 rt.	
Water	(10	mL)	and	EtOAc	(10	mL)	were	added	and	the	aqueous	
phase	was	extracted	with	EtOAc	(3	×	10	mL)	The	organic	extracts	
were	 washed	 with	 brine	 (40	 mL),	 dried	 (MgSO4)	 and	
concentrated	 under	 reduced	 pressure.	 Chromatography	 of	 the	
residue	(0.5:99.5	ether:light	petroleum)	gave	the	title	compound	
46	(0.12	g,	0.17	mmol,	66%)	as	a	colourless	oil,	Rf	=	0.58	(10:90	
ether:light	 petroleum)	 (Found:	 M+	 +	 NH4,	 716.3761.	








115.5,	 118.0	 (t,	 1JC-F	 260.0),	 127.5,	 127.6,	 129.4,	 129.5,	 129.7,	
129.8,	132.3,	133.5,	133.7(2),	135.4,	135.5,	135.9,	136.0,	139.7	





fluoride	 (1	 M	 in	 THF,	 0.81	 mL,	 0.81	 mmol)	 was	 added	 to	 the	
ketone	46	(0.27	g,	0.386	mmol)	in	THF	(3.96	mL)	at	0	°C	and	the	
solution	 stirred	 at	 rt	 for	 15	 h.	 Saturated	 aqueous	 ammonium	
chloride	(10	mL),	water	(10	mL)	and	EtOAc	(20	mL)	were	added	
and	 the	 aqueous	phase	was	 extracted	 into	 EtOAc	 (3	 ×	 20	mL).	
The	 organic	 extracts	 were	 washed	 with	 brine	 (80	 mL),	 dried	
(MgSO4)	 and	 concentrated	 under	 reduced	 pressure.	
Chromatography	of	the	residue	(10:90	ether:light	petroleum	to	
ether)	 gave	 a	mixture	 (1H	NMR)	 of	 the	 hemiacetals	47	 and	48	
(83	mg)	 as	 a	 colourless	 oil.	 Repeated	 trituration	with	 pentane	
gave	the	title	compound	47	(70	mg,	0.315	mmol,	82%)	as	white	









(d,	 3JC-F	 5.8),	 46.5	 (d,	 3JC-F	 2.9),	 58.7,	 68.1	 (dd,	 2JC-F	 21.9,	 20.4),	
98.4	(dd,	2JC-F	30.9,	24.3),	115.5,	121.0	(dd,	1JC-F	260.6,	252.5)	and	
144.6;	 δF	 (377	 MHz,	 benzene-d6)	 -130.10	 (d,	 2JF-F	 240.0)	 and	
-118.89	(d,	2JF-F	238.7);	m/z	 (ES-)	291.3	(100%)	and	221.2	([M	-	
H]-).	










	 2-Difluoromethylenedecan-1-ol	 (54).	Methyllithium	 (1.6	 M	
in	 ether,	 0.37	 mL,	 0.60	 mmol)	 was	 added	 dropwise	 to	 the	
ketone	5228	(68	mg,	0.30	mmol)	and	di-iodomethane	(0.048	mL,	
0.60	 mmol)	 in	 dry	 THF	 (1.8	 mL)	 at	 -78	 °C	 and	 the	 mixture	
allowed	to	warm	to	rt	over	30	min	then	cooled	to	-78	°C.	tert-
Butyllithium	(1.7	M	in	pentane,	5.15	mmol,	3.03	mL)	was	added	
and	 the	mixture	was	 stirred	 at	 rt	 for	 16	 h.	 Aqueous	 hydrogen	
chloride	 (1	M,	 20	mL)	 and	 ether	 (20	mL)	were	 added	 and	 the	
aqueous	 phase	 was	 extracted	 with	 ether	 (3	 ×	 20	 mL).	 The	
organic	extracts	were	washed	with	brine	(80	mL),	dried	(MgSO4)	
and	 concentrated	under	 reduced	pressure.	Chromatography	of	
the	 residue	 (1:99	 to	 5:95	 ether:light	 petroleum)	 gave	 the	 title	
compound	54	 (94	mg,	0.46	mmol,	44%)	as	a	colourless	oil,	Rf	=	
0.18	 (10:90	 ether:light	 petroleum)	 (Found:	 M+,	 206.1477.	












	 1-Bromo-2-(difluoromethylene)decane	 (55).	 Dimethyl	




the	 mixture	 stirred	 at	 rt	 for	 16	 h.	 Saturated	 aqueous	 sodium	
hydrogen	carbonate	(10	mL)	and	DCM	(10	mL)	were	added	and	
the	 aqueous	 phase	was	 extracted	with	 DCM	 (3	 ×	 10	mL).	 The	
organic	extracts	were	washed	with	brine	(40	mL),	dried	(MgSO4)	
and	 concentrated	under	 reduced	pressure.	Chromatography	of	
the	 residue	 (light	petroleum)	gave	 the	 title	 compound	55	 (0.12	
g,	 0.435	 mmol,	 63%)	 as	 a	 colourless	 oil,	 Rf	 =	 0.41	 (light	
petroleum);	 nmax/cm-1	 2956,	 2925,	 2856,	 1735,	 1465,	 1290,	
1223,	1188	and	1058;	δH	(500	MHz,	CDCl3)	0.90	(3	H,	t,	J	7.0,	10-
H3),	1.25-1.35	(10	H,	m,	5	×	CH2),	1.46	(2	H,	m,	4-H2),	2.14	(2	H,	





mmol)	 in	 DCM	 (1.38	 mL),	 dimethyl	 sulfide	 (0.032	 mL,	 0.44	
mmol)	and	the	alcohol	54	 (49	mg,	0.237	mmol)	 in	DCM	(1	mL)	
with	 heating	 the	 crude	 product	 in	 toluene-d8	 (0.5	 mL)	 under	
reflux	 for	 16	h	 gave,	 after	 chromatography	 (light	 petroleum)	 a	
mixture	(57	mg,	0.212	mmol,	89%)	of	the	title	compound	55	and	
2-(bromodifluoromethyl)dec-1-ene	56	 as	a	 colourless	oil,	55:56	








	 Difluorinated	 alcohols	 57:	 general	 procedure.	 Indium	
powder	 (43	mg,	 0.37	mmol)	was	 added	 to	 a	 vigorously	 stirred	
solution	 of	 1-bromo-2-(difluoromethylene)decane	 55	 (50	 mg,	
0.19	mmol)	 in	DMF	 (1.0	mL)	 in	a	10	mL	Schlenk	 tube.	After	10	
min,	 the	 aldehyde	 (0.41	 mmol)	 was	 added	 and	 the	 mixture	
stirred	 for	 14	 h.	Aqueous	 hydrogen	 chloride	 (10%,	 10	mL)	 and	
ether	(10	mL)	were	added	and	the	aqueous	phase	was	extracted	
with	ether	(3	×	30	mL).	The	organic	extracts	were	washed	with	
brine	 (40	mL),	 dried	 (MgSO4)	 and	 concentrated	under	 reduced	
pressure.	 Chromatography	 of	 the	 residue	 (light	 petroleum	 to	
5:95	 ether:light	 petroleum)	 gave	 the	 alcohols	 57	 as	 colourless	
oils.	
	 2,2-Difluoro-3-methylene-1-phenylundecan-1-ol	57a.	(46	mg,	





H2),	2.43	 (1	H,	br.	 s,	OH),	4.93	 (1	H,	 t,	 3JH-F	11.0,	1-H),	5.18	and	
5.31	(each	1	H,	s,	3-CH),	7.33-7.38	(3	H,	m,	ArH)	and	7.40-7.44	(2	
H,	m,	ArH);	δC	 (100	MHz,	CDCl3)	 14.1,	 22.6,	 27.6,	 29.2(2),	 29.3,	
30.5	(t,	3JC-F	2.9),	31.8,	75.4	(t,	2JC-F	30.0),	116.3	(t,	3JC-F	8.0),	121.2	




57b.	 (40	 mg,	 0.12	 mmol,	 65%),	 Rf	 =	 0.65	 (50:50	 ether:light	
petroleum)	 (Found:	 M+	 +	 NH4,	 344.2390.	 C19H32NO2F2	 requires	





3-CH),	6.89	 (2	H,	d,	 J	8.9,	ArH)	and	7.34	 (2	H,	d,	 J	8.5,	ArH);	δC	
(100	MHz,	CDCl3)	14.1,	22.6,	27.6,	29.2(2),	29.4,	30.5	(t,	3JC-F	2.9),	
31.8,	55.2,	75.1	(t,	2JC-F	29.9),	113.5,	116.2	(t,	3JC-F	8.8),	121.2	(t,	
1JC-F	 247.2),	 128.2	 (t,	 3JC-F	 2.2),	 129.0,	 142.9	 (t,	 2JC-F	 22.6)	 and	
159.8;	 δF	 (471	MHz,	 CDCl3)	-109.52	 and	-110.20	 (both	 d,	 2JF-F	
244.7);	m/z	(GC/MS-CI)	327	(M+	+	1).		
	 2,2-Difluoro-3-methylene-1-(3-chlorophenyl)undecan-1-ol	
57c.	 (60	 mg,	 0.17	 mmol,	 93%),	 Rf	 =	 0.2	 (10:90	 ether:light	
petroleum)	(Found:	M+	+	NH4,	348.1897.	C18H29NO35ClF2	requires	





H,	 m,	 ArH)	 and	 7.42-7.44	 (1	 H,	 m,	 ArH);	 δC	 (100	 MHz,	 CDCl3)	
14.1,	22.6,	27.6,	29.2,	29.4,	30.5	 (t,	 3JC-F	 2.9),	 31.8,	74.8	 (t,	 2JC-F	




	 5,5-Difluoro-6-methylenetetradecan-4-ol	 57d.	 (50	 mg,	 0.18	
mmol,	98%),	Rf	=	0.23	(10:90	ether:light	petroleum)	(Found:	M+	






13.8,	 14.1,	 18.8,	 22.6,	 27.8,	 29.2,	 29.3,	 29.4,	 30.5	 (t,	 4JC-F	 2.9),	
31.8,	31.9	(t,	3JC-F	2.2),	72.3	(t,	2JC-F	28.7),	115.5	(t,	3JC-F	8.8),	121.8	











(each	 1	H,	 s,	 5-H);	 δC	 (100	MHz,	 CDCl3)	 14.1,	 16.2	 (t,	 4JC-F	 2.2),	
20.8	 (t,	 4JC-F	 1.5),	 22.6,	27.8,	28.3,	29.2,	29.3,	29.4,	30.4	 (t,	 3JC-F	







	 4,4-Difluoro-2,2-dimethyl-5-methylenetridecan-3-ol	 57f.	 (24	







d,	 4JH-F	 2.5,	 5-H’);	 δC	 (100	MHz,	 CDCl3)	 14.1,	 22.7,	 26.9	 (t,	 4JC-F	
2.2),	27.8,	29.2,	29.4(2),	30.5	(dd,	3JC-F	3.7,	2.2),	31.9,	34.8,	78.1	
(dd,	 2JC-F	 29.5,	 26.5),	 114.8	 (dd,	 3JC-F	 10.3,	 8.1),	 123.0	 (dd,	 1JC-F	










2.08-2.23	 (2	 H,	 m,	 6-H2),	 3.09	 (1	 H,	 br.	 s,	 OH),	 3.86	 and	 3.96	
(each	1	H,	m,	1-H),	4.20	(1	H,	m,	3-H),	5.25	and	5.48	(each	1	H,	s,	








(58).	 N-Methylmorpholine-N-oxide	 (52	 mg,	 0.446	 mmol)	 and	
TPAP	(5	mg,	0.015	mmol)	were	added	to	the	alcohol	40	(0.116	g,	
0.297	mmol)	and	4Å	molecular	sieves	(0.168	g)	in	dry	DCM	(2.0	
mL)	 and	 the	mixture	 stirred	 for	 16	 h	 then	 concentrated	 under	
reduced	 pressure.	 Chromatography	 of	 the	 residue	 (light	
petroleum	 to	 2:98	 ether:light	 petroleum)	 gave	 the	 title	
compound	58	 (90	mg,	0.23	mmol,	78%)	as	a	colourless	oil,	Rf	=	
0.43	 (10:90	 ether:light	 petroleum)	 (Found:	M+	 +	Na,	 411.1568.	
C22H26O2F2SiNa	 requires	 M,	 411.1568);	 nmax/cm-1	 2957,	 2931,	





(t,	 1JC-F	 251.2),	 123.1	 (t,	 3JC-F	 9.6),	 127.7,	 128.3	 (t,	 2JC-F	 25.1),	
129.8,	133.2,		135.5	and	198.2	(t,	2JC-F	32.4);	δF	(471	MHz,	CDCl3)	
-108.32;	m/z	 (ES+)	 427	 (M+	 +	 39,	 25%),	 411	 (M+	 +	 23,	 15)	 and	
102	(100).	
	
	 Methyl	 (E)-	 and	 (Z)-3-(2-tert-butyldiphenylsilyloxyethyl)-




After	 concentration	 under	 reduced	 pressure,	 chromatography	
of	 the	 residue	 (light	 petroleum	 to	 0.5:99.5	 ether:light	
petroleum)	gave	the	title	compound	59	(0.26	g,	0.59	mmol,	84%)	
as	 a	 colourless	 oil,	 Rf	 =	 0.38	 (10:90	 ether:light	 petroleum)	






H,	 m,	 ArH)	 and	 7.66-7.71	 (4	 H,	 m,	 ArH);	 δC	 (100	 MHz,	 CDCl3)	
19.1,	 26.8,	 30.5	 (t,	 3JC-F	 1.5),	 51.5,	 62.4,	 118.7	 (t,	 1JC-F	 243.1),	
120.9	(t,	3JC-F	9.6),	121.2	(t,	3JC-F	8.8),	127.6,	129.6,	131.4	(t,	2JC-F	
28.7),	133.7,	135.6,	149.4	(t,	2JC-F	25.0)	and	165.6;	δF	(471	MHz,	
CDCl3)	 -100.52;	m/z	 (ES+)	 467.3	 (M+	 +	 23,	 100%).	 The	 second	
fraction	was	the	title	compound	60	(36	mg,	0.081	mmol,	11%)	as	
a	colourless	oil,	Rf	=	0.27	 (10:90	ether:light	petroleum)	(Found:	
M+	 +	 Na,	 467.1836.	 C25H30O3F2SiNa	 requires	 M,	 467.1824);	
nmax/cm-1	2953,	2931,	2857,	1735,	1428,	1240,	1196,	1159,	1105,	





(t,	 3JC-F	 3.7),	 51.8,	 61.8,	 118.7	 (t,	 1JC-F	 239.9),	 120.1	 (t,	 3JC-F	 8.8),	
122.9	(t,	3JC-F	5.1),	127.7,	129.7,	132.0	(t,	2JC-F	27.8),	133.4,	135.6,	









and	 the	 mixture	 was	 stirred	 at	 rt	 for	 1	 h.	 Saturated	 aqueous	
ammonium	chloride	(10	mL)	and	DCM	(10	mL)	were	added	and	
the	 aqueous	 phase	 was	 extracted	 into	 DCM	 (3	 ×	 10	 mL).	 The	
organic	extracts	were	washed	with	brine	(40	mL),	dried	(MgSO4)	
and	 concentrated	under	 reduced	pressure.	Chromatography	of	
the	 residue	 (0.25:99.75	 ether:light	 petroleum)	 gave	 the	 title	
compound	61	 (55	mg,	0.11	mmol,	61%)	as	a	colourless	oil,	Rf	=	
0.53	 (5:95	 ether:light	 petroleum)	 (Found:	 M+	 +	 Na,	 523.2809.	







(t,	 4JC-F	2.2),	31.8,	39.3,	58.0,	116.1	 (t,	 1JC-F	251.6),	117.1	 (t,	 3JC-F	
8.8),	127.7,	129.7,	133.2,	135.5,	140.8	(t,	2JC-F	21.9)	and	198.3	(t,	









methylidene(triphenyl)phosphorane	 (37	 mg,	 0.11	 mmol)	 was	
added	 to	 the	 ketone	61	 (32	mg,	 0.064	mmol)	 in	 toluene	 (0.23	
mL)	 and	 the	 mixture	 heated	 at	 70	 °C	 for	 11	 h.	 After	
concentration	under	 reduced	pressure,	 chromatography	of	 the	
residue	 (0.25:99.75	 ether:light	 petroleum)	 gave	 the	 title	
compound	62	(17	mg,	0.031	mmol,	48%)	as	a	colourless	oil,	Rf	=	
0.23	 (5:95	 ether:light	 petroleum)	 (Found:	 M+	 +	 Na,	 579.3080.	
C33H46O3F2SiNa	 requires	 M,	 579.3082);	 nmax/cm-1	 2928,	 2856,	
1729,	 1428,	 1256,	 1200,	 1177,	 1105	 and	 739;	 δH	 (500	 MHz,	














1.6	mmol)	 and	 ethyl	 2-bromo-2,2-difluoroacetate	11	 (0.22	mL,	
1.76	 mmol)	 in	 dry	 THF	 (16	 mL)	 and	 the	 yellow	 mixture	 was	
stirred	at	rt	for	10	min.	Aqueous	hydrogen	chloride	(1	M,	50	mL)	
was	added	slowly	followed	by	ether	(50	mL).	The	aqueous	phase	
was	 extracted	with	 ether	 (3	 ×	 50	mL)	 and	 the	organic	 extracts	
were	 washed	 with	 saturated	 aqueous	 sodium	 thiosulfate	 (50	
mL)	then	brine	(250	mL)	and	dried	(MgSO4).	After	concentration	
under	 reduced	 pressure,	 chromatography	 of	 the	 residue	









H,	 m,	 ArH)	 and	 7.61-7.75	 (4	 H,	 m,	 ArH);	 δC	 (125	 MHz,	 CDCl3)	
13.9,	19.0,	26.8,	30.8,	61.7,	62.9,	70.9	(dd,	2JC-F	29.4,	24.8),	114.6	







mL)	 and	 the	mixture	 stirred	at	 rt	 for	16	h.	After	 concentration	
under	 reduced	 pressure,	 chromatography	 of	 the	 residue	 (light	
petroleum	 to	 0.25:99.75	 ether:light	 petroleum)	 gave	 the	 title	
compound	63	 (0.13	g,	0.30	mmol,	63%)	as	a	colourless	oil,	Rf	=	
0.29	 (10:90	 ether:light	 petroleum)	 (Found:	M+	 +	Na,	 457.1619.	




7.2,	 OCH2CH3),	 7.38-7.48	 (6	 H,	m,	 ArH)	 and	 7.66-7.71	 (4	 H,	m,	
ArH);	 δC	 (100	 MHz,	 CDCl3)	 13.8,	 19.1,	 26.6,	 39.6,	 57.8,	 63.7,	




	 Methyl	 (E)-	 and	 (Z)-5-tert-butyldiphenylsilyloxy-3-








C26H32O5F2SiNa	 requires	 M,	 513.1885);	 nmax/cm-1	 2955,	 2932,	
2858,	1769,	1731,	1279,	1262,	1201,	1181,	1109,	1065,	823	and	





113.1	 (t,	 1JC-F	 254.9),	 123.3	 (t,	 3JC-F	 8.8),	 127.6,	 129.6,	 133.5,	
135.5,	146.0	(t,	2JC-F	22.1),	162.9	(t,	2JC-F	33.9)	and	165.0;	δF	(377	
MHz,	CDCl3)	-107.08;	m/z	(ES+)	513.2	(M+	+	23,	80%),	491.2	(M+	
+	 1,	 20)	 and	 256.9	 (100).	 The	 second	 fraction	 was	 the	 title	
compound	65	 (17	mg,	0.035	mmol,	12%)	as	a	colourless	oil;	δH	
(500	 MHz,	 CDCl3)	 1.07	 [9	 H,	 s,	 SiC(CH3)3],	 1.31	 (3	 H,	 t,	 J	 7.0,	
OCH2CH3),	2.63	(2	H,	t,	J	6.4,	4-H2),	3.72	(3	H,	s,	OCH3),	3.86	(2	H,	
t,	 J	6.7,	 5-H2),	 4.32	 (2	H,	 q,	 J	7.3,	OCH2CH3),	 6.10	 (1	H,	 s,	 2-H),	





and	 ruthenium(III)	 chloride	hydrate	 (16	mg,	 0.062	mmol)	were	
added	 to	 the	 alkene	59	 (0.14	 g,	 0.31	mmol)	 in	 aqueous	 EtOAc	
(1:1,	 1.42	 mL).	 Sodium	 periodate	 (0.066	 g,	 0.31	 mmol)	 was	
added	in	ten	equal	portions	over	5	h	and	the	mixture	stirred	for	
a	 further	 30	min	 before	 saturated	 aqueous	 sodium	 thiosulfate	
(10	mL)	and	EtOAc	(10	mL)	were	added.	The	aqueous	phase	was	
extracted	with	EtOAc	(3	×	10	mL)	and	the	organic	extracts	were	
washed	 with	 brine	 (40	 mL),	 dried	 (MgSO4)	 and	 concentrated	
under	 reduced	 pressure.	 Chromatography	 of	 the	 residue	 (1:99	
to	 50:50	 ether:light	 petroleum)	 gave	 recovered	 alkene	 59	 (61	
mg,	 44%)	 followed	 by	 the	 title	 compound	 	 66	 (65	 mg,	 0.14	
mmol,	44%)	as	a	colourless	oil,	Rf	=	0.60	(ether)	(Found:	M+	+	Na,	
501.1898.	C25H32O5F2SiNa	requires	M,	501.1885);	nmax/cm-1	3401,	
2952,	 2932,	 2889,	 2857,	 1727,	 1428,	 1260,	 1200,	 1105,	 1081,	
1039,	822	and	738;	δH	(400	MHz,	CDCl3)	1.06	[9	H,	s,	SiC(CH3)3],	


















in	 DCM	 (1.2	 mL).	 The	 mixture	 was	 stirred	 at	 rt	 for	 30	 min,	
filtered	 and	 concentrated	 under	 reduced	 pressure	 to	 give	 the	
aldehyde	 67	 that	 was	 azeotroped	 with	 benzene.	 1-Bromo-3-
methylbut-2-ene	 (0.14	 mL,	 1.23	 mmol)	 was	 added	 to	 this	
aldehyde	 in	 THF	 (2.4	 mL)	 and	 the	 solution	 was	 added	 to	 a	
suspension	 of	 zinc	 dust	 (80	 mg,	 1.23	 mmol)	 and	 titanocene	
dichloride	 (3	mg,	0.012	mmol)	 in	 THF	 (2.45	mL)	 that	had	been	




(MgSO4)	 and	 concentrated	 under	 reduced	 pressure.	
Chromatography	 of	 the	 residue	 (10:90	 ether:light	 petroleum)	
gave	 the	 title	 compound	 68	 (41	 mg,	 0.079	 mmol,	 65%)	 as	 a	
colourless	oil,	Rf	=	0.40	(30:70	ether:light	petroleum)	(Found:	M+	
+	Na,	539.2392.	C29H38O4F2SiNa	requires	M,	539.2405);	nmax/cm-1	





5.04-5.11	 (2	H,	m,	8-H2),	5.99	 (1	H,	ddq,	 J	17.4,	10.8,	1.2,	7-H),	
6.23	(1	H,	d,	J	2.8,	2-H),	7.36-7.47	(6	H,	m,	ArH)	and	7.65-7.70	(4	
H,	 m,	 ArH);	 δC	 (125	 MHz,	 CDCl3)	 19.1,	 24.1	 (t,	 4JC-F	 3.6),	 24.2,	
26.8,	 30.9,	 41.0,	 51.5,	 63.3,	 76.5	 (dd,	 2JC-F	 30.9,	 26.4),	 113.3,	
121.4	 (dd,	 3JC-F	 11.8,	 8.2),	 122.7	 (dd,	 1JC-F	 259.3,	 249.3),	 127.7,	









(0.78	 mL)	 and	 the	 mixture	 stirred	 at	 rt	 for	 30	 min	 then	
concentrated	 under	 reduced	 pressure.	 Chromatography	 of	 the	
residue	 (2:98	 to	 10:90	 ether:light	 petroleum)	 gave	 the	 title	
compound	69	(27	mg,	0.053	mmol,	87%)	as	a	colourless	oil,	Rf	=	
0.48	 (10:90	 ether:light	 petroleum)	 (Found:	M+	 +	Na,	 537.2264.	




5.15	 (1	H,	d,	 J	17.4,	8-H),	 5.19	 (1	H,	d,	 J	10.8,	8-H’),	 5.95	 (1	H,	
ddt,	J	17.4,	10.8,	1.0,	7-H),	6.18	(1	H,	t,	J	1.6,	2-H),	7.36-7.45	(6	
H,	 m,	 ArH)	 and	 7.65-7.69	 (4	 H,	 m,	 ArH);	 δC	 (125	 MHz,	 CDCl3)	
19.1,	24.0	(t,	4JC-F	1.8),	26.7,	30.5,	49.7,	51.6,	62.1,	116.1,	116.7	
(t,	 1JC-F	 257.5),	 123.3	 (t,	 3JC-F	 9.9),	 127.6,	 129.5,	 133.6,	 135.6,	
139.7,	146.7	(t,	2JC-F	21.7),	165.0	and	200.5	(t,	2JC-F	28.9);	δF	(471	





Hydrogen	 fluoride.pyridine	 complex	 (70%	 HF,	 0.2	 mL)	 was	
added	 rapidly	 to	 the	 ketone	 69	 (34	 mg,	 0.066	 mmol)	 and	
pyridine	(0.39	mL)	in	THF	(3.9	mL)	at	0	°C	and	the	mixture	stirred	
for	 2.5	 h.	 Saturated	 aqueous	 sodium	bicarbonate	 (10	mL)	was	
added	 and	 the	 mixture	 was	 stirred	 at	 rt	 for	 1	 h.	 After	 the	
addition	 of	 EtOAc	 (10	 mL),	 the	 aqueous	 phase	 was	 extracted	
with	 EtOAc	 (3	 ×	 10	mL)	 and	 the	organic	 extracts	were	washed	
with	 brine	 (40	 mL),	 dried	 (MgSO4)	 and	 concentrated	 under	
reduced	 pressure.	 Chromatography	 of	 the	 residue	 (10:90	
ether:light	petroleum)	gave	the	title	compound	70	(15	mg,	0.054	
mmol,	82%)	as	a	colourless	oil	which	solidified	on	cooling,	Rf	 =	
0.31	 (30:70	 ether:light	 petroleum),	 m.p.	 54-56	 °C	 (Found:	 C,	
56.61;	H,	6.64.	C13H18O4F2	requires	C,	56.50;	H,	6.60%;	Found:	M+	
+	Na,	 299.1071.	 C13H18O4F2Na	 requires	M,	 299.1071);	nmax/cm-1	
3515,	 2956,	 2918,	 2850,	 1729,	 1127	 and	 1061:	 δH	 (400	 MHz,	














(6.3	mL)	 at	-78	 °C	 for	 5	min	until	 a	 blue	 colour	persisted.	 The	
system	was	purged	with	oxygen	for	10	min,	triphenylphosphine	
(0.31	g,	 1.16	mmol)	was	added	and	 the	mixture	was	 stirred	at	
r.t.	 for	 3	 h.	 Chromatography	 of	 the	 residue	 (2:98	 to	 3:97	
ether:light	petroleum)	gave	the	title	compound	72	(0.29	g,	0.56	
mmol,	 96%),	 as	 a	 colourless	 oil,	 Rf	 =	 0.23	 (10:90	 ether:light	
petroleum)	 (Found:	M+	 +	Na,	 543.3352.	 C25H56O5Si3Na	 requires	




















powder	 (49	 mg,	 0.42	 mmol)	 and	 3-bromo-3,3-difluoroprop-1-
ene	37	 (66	mg,	0.42	mmol)	were	added	 to	a	vigorously	 stirred	






the	 residue	 (1:99	 to	 5:95	 ether:light	 petroleum)	 gave	 the	 title	
compound	73	 (56	mg,	 0.094	mmol,	 66%	 from	 alkene	71),	 as	 a	
colourless	 oil,	 a	 53:47	 mixture	 in	 favour	 of	 the	 less	 polar	
diastereoisomer	 (19F	 NMR),	 Rf	 =	 0.19	 (10:90	 ether:light	
petroleum)	(Found:	M+	+	Na,	621.3619.	C28H60O5F2Si3Na	requires	
M,	 621.3614);	 nmax/cm-1	 2954,	 2929,	 2858,	 1472,	 1420,	 1250,	
1101,	 1055,	 1032	 and	 1004;	m/z	 (ES+)	 621.4	 (M+	 +	 23,	 30%),	
599.4	 (M+	+	1,	 20)	 and	481.3	 (100).	Repeated	 chromatography	










65.4,	 69.0,	 69.7,	 70.7	 (t,	 2JC-F	 29.8),	 80.0,	 95.6,	 119.9	 (dd,	 1JC-F	
239.2,	241.9),	120.6	(t,	3JC-F	9.0)	and	130.4	(t,	2JC-F	25.3);	δF	(377	
MHz,	CDCl3)	-114.86	(d,	2JF-F	249.7)	and	-108.30	(d,	2JF-F	248.3).	
Further	 elution	 gave	 the	 more	 polar	 diastereoisomer;	 δH	 (400	







H);	 δC	 (100	 MHz,	 CDCl3)	 -4.8(2),	 -4.6,	 -4.3,	 -1.5,	 16.9,	 17.9,	
18.0,	18.1,	25.8(2),	36.0,	36.8	(t,	3JC-F	2.2),	65.7,	68.7,	69.9,	70.9	
(t,	 2JC-F	29.9),	80.0,	95.3,	119.9	 (dd,	 1JC-F	239.9,	242.1),	120.6	 (t,	






0.011	mmol)	 were	 added	 to	 a	 suspension	 of	 a	mixture	 of	 the	
diastereoisomers	of	the	alcohol	73	(63	mg,	0.105	mmol)	and	4Å	
molecular	sieves	(65	mg)	in	DCM	(1.1	mL).	The	mixture	stirred	at	
rt	 for	 16	 h	 then	 concentrated	 under	 reduced	 pressure.	
Chromatography	 of	 the	 residue	 (0.5:99.5	 to	 5:95	 ether:light	
petroleum)	 gave	 the	 title	 compound	 74	 as	 a	 colourless	 oil	 (47	
mg,	 0.079	mmol,	 75%),	Rf	 =	 0.59	 (10:90	ether:light	 petroleum)	
(Found:	 M+	 +	 Na,	 619.3461.	 C28H58O5F2Si3Na	 requires	 M,	
619.3458);	nmax/cm-1	2954,	2929,	2887,	2858,	1746,	1472,	1379,	









17.1,	 17.9,	 18.0,	 18.1,	 25.8,	 25.9,	 36.8,	 45.2,	 65.5,	 66.0,	 68.9,	
79.7,	95.5,	114.2	(t,	1JC-F	249.4),	122.9	(t,	3JC-F	9.5),	128.4	(t,	2JC-F	






phosphorane	 (0.12	g,	 0.36	mmol)	was	added	 to	 the	 ketone	74	
(0.18	g,	0.30	mmol)	in	toluene	(1.5	mL)	and	the	mixture	heated	
at	 90	 °C	 for	 16	 h.	 After	 allowing	 to	 cool	 to	 rt,	 the	 reaction	
mixture	 was	 concentrated	 under	 reduced	 pressure.	
Chromatography	 of	 the	 residue	 (1:99	 to	 2:98	 ether:light	













H’),	 5.92	 (1	 H,	 m,	 2’-H)	 and	 6.20	 (1	 H,	 s,	 2-H);	 δC	 (100	 MHz,	
CDCl3)	-4.8(2),	-4.6,	-4.1,	-1.5,	 17.3,	 17.9,	 18.0,	 18.1,	 25.9(2),	
35.6,	36.1,	51.5,	65.2,	68.9,	69.1,	80.1,	95.9,	118.9	(t,	1JC-F	240.7),	
120.6	(t,	3JC-F	8.8),	122.0	(t,	3JC-F	8.0),	131.8	(t,	2JC-F	28.4),	149.4	(t,	
2JC-F	 24.8)	 and	 165.8;	 δF	 (377	 MHz,	 CDCl3)	 -99.44	 and	 -98.74	






(0.34	 mL)	 and	 ruthenium(III)	 chloride	 hydrate	 (40	 mg,	 0.016	
mmol)	were	added	 to	 the	alkene	75	 (51	mg,	0.078	mmol)	 in	 a	
mixture	 of	 EtOAc	 and	 water	 (1:1,	 0.34	mL).	 Sodium	 periodate	
(20	mg,	0.094	mmol)	was	then	added	in	ten	equal	portions	over	
9	 h.	 After	 stirring	 for	 a	 further	 30	 min,	 saturated	 aqueous	
sodium	 sulfite	 (5	 mL)	 and	 EtOAc	 (5	 mL)	 were	 added	 and	 the	
aqueous	phase	was	extracted	with	EtOAc	(3	×	5	mL).	The	organic	
extracts	 were	 washed	 with	 brine	 (20	 mL),	 dried	 (MgSO4)	 and	
concentrated	 under	 reduced	 pressure.	 Chromatography	 of	 the	
residue	 (10:90	 to	 40:60	 ether:light	 petroleum)	 gave	 recovered	





mg,	 0.048	mmol,	 61%),	 as	 a	 colourless	 oil,	 a	 55:45	mixture	 of	
diastereoisomers	 (19F	 NMR),	 Rf	 =	 0.15	 (50:50	 ether:light	
petroleum)	(Found:	M+	+	Na,	709.3753.	C31H64O8F2Si3Na	requires	


















1JC-F	 253.3,	 244.2),	 122.3	 	 and	 123.6	 (each	 dd,	 3JC-F	 11.3,	 7.7),	
147.8	 (dd,	 2JC-F	 23.5,	 20.8),	 149.5	 (dd,	 2JC-F	 24.4,	 19.9)	 and	
165.6(2);	 δF	 (471	 MHz,	 CDCl3)	 -115.11	 (0.55	 F,	 d,	 2JF-F	 249.9),	
-113.55	 (0.45	 F,	 d,	 2JF-F	 249.9),	-107.39	 (0.55	 F,	 d,	 2JF-F	 249.9)	





trimethylsilylethoxy)methoxynon-2-enoate	 (77).	 Solid	 sodium	
carbonate	(60	mg,	0.56	mmol)	and	lead(IV)	acetate	(0.10	g,	0.22	
mmol)	were	 added	 to	 the	 diol	76	 (0.13	 g,	 0.186	mmol)	 in	 dry	
DCM	 (1.9	 mL).	 After	 stirring	 at	 rt	 for	 90	 min,	 the	 reaction	
mixture	 was	 filtered	 through	 Celite®	 and	 concentrated	 under	
reduced	 pressure	 to	 give	 an	 oil	 that	was	 dissolved	 in	 THF	 (3.8	
mL).	 1-Bromo-3-methylbut-2-ene	 (0.22	 mL,	 1.86	 mmol)	 was	
added	 and	 the	 solution	 added	 to	 a	 stirred	 suspension	 of	 zinc	
dust	 (0.12	g,	1.86	mmol)	and	titanocene	dichloride	 (5	mg,	0.02	
mmol)	in	THF	(3.8	mL).	After	stirring	for	16	h,	aqueous	hydrogen	
chloride	 (10%,	 20	 mL)	 and	 EtOAc	 (20	 mL)	 were	 added.	 The	
aqueous	 phase	was	 extracted	with	 EtOAc	 (3	 ×	 20	mL)	 and	 the	
organic	extracts	were	washed	with	brine	(60	mL),	dried	(MgSO4)	
and	 concentrated	under	 reduced	pressure.	Chromatography	of	
the	 residue	 (3:97	 to	 5:95	 ether:light	 petroleum)	 gave	 the	 title	
compound	 77	 (94	 mg,	 0.13	 mmol,	 70%)	 as	 a	 colourless	 oil,	 a	
50:50	mixture	 of	 diastereoisomers	 (19F	 NMR),	Rf	 =	 0.49	 (30:70	
ether:light	 petroleum)	 (Found:	 M+	 +	 Na,	 747.4294.	
C35H70O7F2Si3Na	 requires	 M,	 747.4295);	 nmax/cm-1	 3449,	 2954,	
2929,	 2894,	 2857,	 1730,	 1472,	 1463,	 1378,	 1362,	 1251,	 1196,	
1180,	1151,	1103,	1071,	1057,	1033,	835	and	775;	δH	(400	MHz,	





4-H),	 3.08	 (0.5	H,	dd,	 J	12.8,	 7.0,	 4-H’),	 3.18	 (0.5	H,	dd,	 J	12.8,	
8.6,	4-H’),	3.44-3.56	 (3	H,	m,	7-H,	2’-H,	OHCHCH2Si),	3.68	 (1	H,	
m,	OHCHCH2Si),	 3.73	 (3	H,	 s,	 OCH3),	 4.04	 (1.5	H,	m,	 8-H,	 5-H),	
4.12	(0.5	H,	m,	5-H),	4.71	and	4.72	(each	1	H,	d,	J	7.0,	OHCHO),	
5.05-5.12	(2	H,	m,	5’-H2),	6.00	(1	H,	m,	4’-H)	and	6.16	and	6.21	
(each	 0.5	 H,	m,	 2-H);	 δC	 (100	MHz,	 CDCl3)	-4.8(3),	-4.7,	-4.6,	
-4.1,	-4.0,	-1.5,	15.3,	17.1,	17.2,	17.9,	18.0,	24.0(2),	24.2,	24.4,	
25.8,	 25.9(2),	 35.4,	 35.9,	 36.0,	 36.3,	 41.2,	 41.3,	 51.4(2),	 65.2,	
65.3,	 65.8,	 68.8(2),	 69.1,	 69.7,	 77.2,	 78.1	 (dd,	 2JC-F	 31.4,	 25.5),	
78.2,	80.4,	80.7,	95.9(2),	112.5,	112.9,	113.4,	113.8,	121.8	(t,	3JC-F	
9.5),	 122.4	 (dd,	 1JC-F	 253.8,	 250.9),	 122.6	 (dd,	 3JC-F	 11.7,	 7.3),	
122.8	(dd,	1JC-F	257.4,	247.2),	144.1,	144.3,	149.6	(dd,	2JC-F	23.3,	
21.1),	151.1	(dd,	2JC-F	24.8,	21.2),	165.8	and	165.9;	δF	(377	MHz,	
CDCl3)	 -113.53	 (0.5	 F,	 d,	 2JF-F	 246.9),	 -112.33	 (0.5	 F,	 d,	 2JF-F	
245.6),	 -99.26	 (0.5	 F,	 d,	 2JF-F	 245.6)	 and	 -98.71	 (0.5	 F,	 d,	 2JF-F	






Methylmorpholine-N-oxide	 (31	 mg,	 0.265	 mmol)	 and	 TPAP	 (7	
mg,	0.02	mmol)	were	added	 to	a	 suspension	of	 the	alcohol	77	
(96	mg,	 0.13	mmol)	 and	 4Å	molecular	 sieves	 (0.11	 g)	 in	 DCM	
(0.89	 mL)	 and	 the	 mixture	 was	 stirred	 at	 rt	 for	 16	 h	 then	
concentrated	 under	 reduced	 pressure.	 Chromatography	 of	 the	
residue	 (2:98	 to	 3:97	 ether:light	 petroleum)	 gave	 the	 title	
compound	78	as	a	colourless	oil	(57	mg,	0.079	mmol,	60%),	Rf	=	
0.44	 (10:90	 ether:light	 petroleum)	 (Found:	M+	 +	Na,	 745.4164.	
C35H68O7F2Si3Na	 requires	 M,	 745.4139);	 nmax/cm-1	 2953,	 2929,	
2887,	 2857,	 1731,	 1472,	 1362,	 1250,	 1197,	 1180,	 1101,	 1054,	
1033,	 832,	 809	 and	774;	 δH	 (400	MHz,	 CDCl3)	 0.01	 (9	H,	 s,	 3	 ×	








-1.5,	 17.2,	 17.9,	 18.0,	 18.1,	 24.1(2),	 25.9(2),	 35.7,	 36.0,	 49.8,	








a	 suspension	 of	 magnesium	 bromide	 (64	 mg,	 0.35	 mmol)	 in	
ether	 (0.23	mL)	 followed	by	 the	SEM-protected	hydroxyketone	
78	 (18	 mg,	 0.025	 mmol)	 in	 ether	 (0.23	 mL),	 and	 the	 mixture	
stirred	 at	 rt	 for	 2	 h.	 Water	 (10	 mL)	 and	 EtOAc	 (10	 mL)	 were	
added	and	the	aqueous	phase	extracted	with	EtOAc	(3	×	10	mL).	
The	 organic	 extracts	 were	 washed	 with	 brine	 (40	 mL),	 dried	
(MgSO4)	 and	 concentrated	 under	 reduced	 pressure.	
Chromatography	 of	 the	 residue	 (3:97	 ether:light	 petroleum)	





colourless	 oil,	 Rf	 =	 0.32	 (10:90	 ether:light	 petroleum)	 (Found:	
[M-H]-,	591.3346.	C29H53O6F2Si2	requires	M,	591.3349);	nmax/cm-1	
2954,	 2930,	 2887,	 2857,	 1731,	 1472,	 1463,	 1363,	 1252,	 1197,	







H,	 dd,	 J	 17.4,	 10.8,	 4’-H)	 and	 6.14	 (1	 H,	 s,	 2-H);	 δC	 (125	MHz,	
CDCl3)	-5.0(2),	 -4.4,	-4.2,	 17.9,	 18.0,	 20.1,	 24.0(2),	 25.8,	 25.9,	
35.4,	40.5,	49.8	(t,	3JC-F	1.8),	51.6,	68.4,	71.7,	71.8,	116.2,	116.8	
(t,	1JC-F	259.1),	123.8	(t,	3JC-F	9.0),	139.7,	147.4	(t,	2JC-F	20.8),	165.2	






enyl)non-2-enoate	 (80).	 2,4,6-Trichlorobenzoyl	 chloride	 (0.015	
mL,	0.098	mmol)	and	triethylamine		(0.03	mL,	0.22	mmol)	were	
added	 to	 butanoic	 acid	 (9	µL,	 0.1	mmol)	 in	 toluene	 (0.25	mL)	
and	 the	 solution	 stirred	at	 rt	 for	1.5	h.	 The	alcohol	79	 (29	mg,	
0.049	mmol)	and	DMAP	(6	mg,	0.049	mmol)	in	toluene	(0.5	mL)	
were	 added	 and	 the	 solution	 stirred	 at	 rt	 for	 16	 h.	 Saturated	
aqueous	 ammonium	 chloride	 (10	mL)	 and	 ether	 (10	mL)	were	
added	and	the	aqueous	phase	extracted	with	ether	(3	×	10	mL).	
The	 organic	 extracts	 were	 washed	 with	 brine	 (40	 mL),	 dried	
(MgSO4)	 and	 concentrated	 under	 reduced	 pressure.	
Chromatography	 of	 the	 residue	 (1:99	 to	 2:98	 ether:light	















36.4,	 49.8,	 51.7,	 67.5,	 67.9,	 73.5,	 116.2,	 116.7	 (t,	 1JC-F	 258.2),	
124.0	 (t,	 3JC-F	 9.0),	 139.7,	 146.6	 (t,	 2JC-F	 21.7),	 165.2,	 173.0	 and	






oxopent-4-enyl)non-2-enoate	 (81).	 Following	 the	 procedure	
outlined	 for	 the	 synthesis	 of	 the	 ester	 80,	 2-methylpropanoic	
acid	 (0.038	 mL,	 0.41	 mmol)	 in	 dry	 toluene	 (1.0	 mL),	 2,4,6-
trichlorobenzoyl	 chloride	 (0.063	mL,	 0.41	mmol),	 triethylamine	
(0.11	mL,	 0.81	mmol),	 the	 alcohol	79	 (0.11	 g,	 0.20	mmol)	 and	
DMAP	 (25	 mg,	 0.20	 mmol)	 in	 toluene	 (2.0	 mL),	 after	
chromatography	 (1:99	 to	2:98	ether:light	petroleum),	 gave	 the	
title	 compound	81	 (0.125	 g,	 0.189	mmol,	 94%)	 as	 a	 colourless	
oil,	Rf	 =	 0.54	 (10:90	 ether:light	 petroleum),	 [α]D20	 =	 0.1	 (c	 1.0,	









4.84	 (1	H,	ddd,	 J	10.7,	4.1,	1.6,	7-H),	5.17	 (1	H,	d,	 J	17.4,	5’-H),	
5.21	(1	H,	d,	 J	10.6,	5’-H’),	5.96	(1	H,	dd,	 J	17.4,	10.6,	4’-H)	and	
6.14	 (1	 H,	 s,	 2-H);	 δC	 (125	MHz,	 CDCl3)	-4.9,	-4.8,	-4.6,	-4.0,	










yl)tetrahydro-4H-pyran	 (82).	 Hydrogen	 fluoride-pyridine	
complex	 (0.24	mL)	was	 added	 to	 the	 ketone	78	 (57	mg,	 0.079	
mmol)	 and	 pyridine	 (0.4	 mL)	 in	 THF	 (4.0	 mL)	 at	 0	 °C	 and	 the	
mixture	 stirred	 for	 16	 h.	 Saturated	 aqueous	 sodium	 hydrogen	
carbonate	 (10	mL)	was	 added	 and	 the	mixture	 stirred	 for	 1	 h.	
Ethyl	 acetate	 (10	mL)	was	 then	 added	 and	 the	 aqueous	 phase	
was	extracted	with	EtOAc	(3	×	10	mL).	The	organic	extracts	were	
washed	 with	 brine	 (40	 mL),	 dried	 (MgSO4)	 and	 concentrated	
under	 reduced	 pressure.	 Chromatography	 of	 the	 residue	
(0.1:99.9	to	0.2:99.8	methanol:DCM)	gave	the	title	compound	82	
(26	 mg,	 0.053	 mmol,	 67%)	 as	 a	 colourless	 oil,	 Rf	 =	 0.41	 (4:96	
methanol:DCM)	 (Found:	 M+	 +	 Na,	 517.2435.	 C23H40O7F2SiNa	
requires	M,	517.2409;	nmax/cm-1	3394,	2953,	1725,	1674,	1436,	
1370,	1280,	1250,	1202,	1178,	1033,	920,	860	and	836;	δH	(500	




H,	 OHCHCH2Si),	 3.68	 (1	 H,	m,	 OHCHCH2Si),	 3.75	 (1	 H,	 d,	 J	 3.5,	
OH),	4.18	(1	H,	dt,	J	13.9,	2.2,	5-H’),	4.37	(1	H,	br.	t,	J	10.7,	6-H),	
4.59	and	4.60	(each	1	H,	d,	J	7.3,	OHCHO),	5.03	(1	H,	dd,	J	10.7,	
1.3,	4’-H),	5.07	 (1	H,	d,	 J	17.7,	1.3,	4’-H’),	6.29	 (1	H,	dd,	 J	17.7,	
10.7,	 3’-H)	 and	 6.50	 (1	 H,	 dd,	 J	 3.8,	 1.9,	 4-CH);	 δC	 (125	 MHz,	
benzene-d6)	-1.3,	 18.3,	 19.7,	 22.8,	 23.7,	 34.3,	 37.6,	 46.5,	 51.4,	
67.1,	 67.3,	 70.7,	 85.6,	 98.5,	 99.4	 (dd,	 2JC-F	 30.7,	 24.4),	 114.0,	












(0.064	 mL,	 1.189	 mmol)	 was	 added	 to	 a	 suspension	 of	
magnesium	 bromide	 (0.11	 g,	 0.59	 mmol)	 in	 ether	 (0.39	 mL)	
followed	by	the	SEM-ether	82	(21	mg,	0.043	mmol)	in	ether	(0.4	
mL)	 and	 the	mixture	was	 stirred	 at	 rt	 for	 24	 h.	Water	 (10	mL)	
and	 EtOAc	 (10	 mL)	 were	 added	 and	 the	 aqueous	 phase	 was	
extracted	 with	 EtOAc	 (3	 ×	 10	 mL).	 The	 organic	 extracts	 were	
washed	 with	 brine	 (40	 mL),	 dried	 (MgSO4)	 and	 concentrated	
under	 reduced	 pressure.	 Chromatography	 of	 the	 residue	 (1:99	
to	4:96	methanol:DCM)	gave	the	title	compound	83	(11	mg,	0.03	
mmol,	70%)	as	a	 colourless	oil,	Rf	 =	0.29	 (4:96	methanol:DCM)	







H,	m,	6-H,	OH),	5.04-5.14	 (2	H,	m,	4’-H2),	6.36	 (1	H,	dd,	 J	17.7,	
10.8,	 3’-H)	 and	 6.50	 (1	 H,	 dd,	 J	 3.6,	 1.8,	 4-CH);	 δC	 (125	 MHz,	
benzene-d6)	19.9,	22.9(m),	23.9(m),	34.3,	39.4,	46.4,	51.5,	67.2,	
71.6,	73.0,	99.5	(dd,	2JC-F	30.7,	24.4),	113.9,	117.6	(dd,	3JC-F	13.5,	
6.3),	 118.4	 (dd,	 1JC-F	 264.5,	 244.6),	 144.6,	 148.8	 (dd,	 2JC-F	 20.8,	
18.1)	and	166.7;	δF	(377	MHz,	benzene-d6)	-121.53	and	-104.94	







yl)tetrahydro-4H-pyrans	 (84)	 and	 (86).	 Hydrogen	 fluoride-
pyridine	complex	 (0.12	mL)	was	added	 to	 the	bis-silyl	ether	80	
(25	mg,	0.038	mmol)	and	pyridine	(0.2	mL)	in	THF	(1.9	mL)	at	0	
°C	and	the	mixture	stirred	 for	16	h.	Saturated	aqueous	sodium	
hydrogen	 carbonate	 (10	 mL)	 was	 added	 and	 the	 mixture	 was	
stirred	 for	 1	 h.	 Ethyl	 acetate	 (10	 mL)	 was	 added	 and	 the	
aqueous	 phase	 was	 extracted	 with	 EtOAc	 (3	 ×	 10	 mL).	 The	
organic	extracts	were	washed	with	brine	(40	mL),	dried	(MgSO4)	
and	 concentrated	under	 reduced	pressure.	Chromatography	of	
the	 residue	 (40:60	 ether:light	 petroleum)	 gave	 the	 title	
compound	 84	 (7	 mg,	 0.016	 mmol,	 42%)	 as	 a	 colourless	 oil	
containing	 ca.	 10%	 of	 the	 regioisomer	 86,	 Rf	 =	 0.41	 (4:96	











19.7,	22.3(m),	24.0(m),	34.2,	36.5,	37.0,	46.6	 (t,	 3JC-F	 2.7),	51.4,	
66.7,	69.3,	74.5,	99.7	(dd,	2JC-F	31.6,	24.4),	114.7,	117.8	(dd,	3JC-F	
13.5,	 6.3),	 118.3	 (dd,	 1JC-F	 264.5,	 242.8),	 144.7,	 148.7	 (dd,	 2JC-F	
21.7,	19.0),	166.4	and	174.3;	δF	(377	MHz,	benzene-d6)	-120.93	
and	-105.01	(each	d,	2JF-F	244.2);	m/z	(ES+)	457.4	(M+	+	23,	80%)	
and	 417.4	 (M+	 -	 17,	 100).	 Further	 elution	 gave	 the	 title	
compound	86	 (7	mg,	0.016	mmol,	42%)	as	a	colourless	oil,	Rf	=	
0.35	 (4:96	 methanol:DCM)	 (Found:	 M+	 +	 Na,	 457.2015.	
C21H32O7F2Na	 requires	 M,	 457.2014);	 nmax/cm-1	 3435,	 2955,	
2935,	 2878,	 1724,	 1674,	 1457,	 1436,	 1369,	 1281,	 1245,	 1198,	
1177,	 1117,	 1064,	 1010,	 920,	 881	 and	 823;	 δH	 (400	 MHz,	







H,	 dd,	 J	 3.7,	 2.0,	 4-CH);	 δC	 (125	 MHz,	 benzene-d6)	 14.0,	 16.3,	
19.1,	22.7,	23.9(m),	34.3,	36.7,	38.8,	46.5,	51.5,	67.1,	70.5,	73.6,	
99.3	(dd,	2JC-F	30.7,	24.4),	114.3,	117.6	(dd,	3JC-F	12.6,	5.4),	118.4	
(dd,	 1JC-F	263.6,	244.6),	144.5,	148.6	 (dd,	 2JC-F	21.7,	19.0),	166.5	
and	173.4;	δF	(377	MHz,	benzene-d6)	-121.41	(d,	2JF-F	242.9)	and	







en-2-yl)tetrahydro-4H-pyrans	 (85)	 and	 (87).	 Following	 the	
procedure	outlined	for	the	synthesis	of	the	esters	84	and	86,	the	
hydrogen	fluoride-pyridine	complex	(0.32	mL),	the	bis-silyl	ether	
81	 (67	mg,	 0.101	mmol)	 and	 pyridine	 (0.5	mL)	 in	 dry	 THF	 (5.1	
mL),	 after	 chromatography	 (70:30	 ether:light	 petroleum)	 gave	
the	title	compound	85	(10	mg,	0.023	mmol,	23%)	as	a	colourless	
oil,	Rf	=	0.34	(70:30	ether:light	petroleum);	[α]D20	=	-54	(c	0.50,	




d,	 J	 4.0,	 1’-H3),	 1.49	 (3	H,	 s,	 2’-CH3),	 1.58-1.64	 (2	H,	m,	 1’’-H2),	
2.19-2.33	[2	H,	m,	C(O)CH,	5-H],	3.19	(1	H,	d,	J	3.9,	OH),	3.20	(3	
H,	s,	OCH3),	3.47	(1	H,	m,	3’’-H),	4.08	(1	H,	m,	6-H),	4.18	(1	H,	dt,	
J	14.0,	2.4,	5-H’),	5.07	 (1	H,	dd,	 J	17.6,	1.4,	4’-H),	5.13	 (1	H,	m,	
2’’-H),	5.19	(1	H,	dd,	J	10.7,	1.3,	4’-H’)	and	6.42-6.51	(2	H,	m,	4-
CH,	 3’-H);	 δC	 (101	 MHz,	 benzene-d6)	 19.1,	 19.2,	 19.4,	 19.7,	
21.9(m),	 23.7(m),	 33.9(m),	 34,3,	 36.5,	 46.3	 (t,	 3JC-F	 2.5),	 51.0,	
66.3,	69.0,	73.8,	98.8	(dd,	2JC-F	31.8,	24.6),	114.5,	117.4	(dd,	3JC-F	




















4-CH);	 δC	 (101	 MHz,	 benzene-d6)	 15.8,	 19.1,	 19.2,	 22.3(m),	
23.5(m),	 33.9(m),	 34.3,	 38.4,	 46.1,	 51.1,	 66.8,	 70.2,	 73.1,	 98.9	
(dd,	2JC-F	31.3,	24.8),	114.1,	117.3	(dd,	3JC-F	13.1,	6.1),	118.1	(dd,	







Osmium	 tetroxide	 in	 tert-butanol	 (2.5%,	 0.37	 mL)	 and	 N-
methylmorpholine-N-oxide	 (46	mg,	 0.40	mmol)	were	 added	 to	
the	diene	77	(0.19	g,	0.26	mmol)	in	tert-butanol-water	(1:1,	2.63	




and	 concentrated	 under	 reduced	 pressure	 to	 give	 the	
dihydroxylated	 intermediate	 (Found:	 M+	 +	 H,	 759.4490.	




min,	 filtered	 through	 Celite®	 and	 concentrated	 under	 reduced	
pressure.	 Chromatography	 of	 the	 residue	 (10:90	 to	 20:80	
ether:light	petroleum)	gave	the	title	compound	90	(0.16	g,	0.22	
mmol,	 82%)	 as	 a	 colourless	 oil,	 a	 50:50	 mixture	 of	
diastereoisomers	 (19F	 NMR),	 Rf	 =	 0.48	 (40:60	 ether:light	
petroleum),	 [α]D27	 =	 -18.8	 (c	 2.0,	 ether)	 (Found:	 M+	 +	 Na,	
749.4049.	 C34H68O8F2Si3Na	 requires	 M,	 749.4082);	 nmax/cm-1	
2953,	 2929,	 2857,	 1728,	 1472,	 1362,	 1250,	 1180,	 1101,	 1055,	
1031	and	832;	δH	(400	MHz,	CDCl3)	0.05	(9	H,	s,	3	×	SiCH3),	0.05,	
0.06,	 0.07	 and	 0.08	 (each	 3	 H,	 s,	 SiCH3),	 0.87(2)	 and	 0.88(2)	





(0.5	H,	 dd,	 J	14.4,	 6.6,	 6-H’),	 3.30	 (0.5	H,	 dd,	 J	13.1,	 8.8,	 6-H’),	





0.5	 H,	 s,	 1-H);	 δC	 (100	 MHz,	 CDCl3)	 -4.8,	 -4.7(2),	 -4.6,	 -4.1,	
-4.0,	-1.5,	17.0,	17.1,	18.0,	18.1,	18.7	 (t,	 4JC-F	2.0),	18.8	 (t,	 4JC-F	
2.9),	 19.7(m),	 19.8(m),	 25.8,	 25.9(2),	 35.3,	 35.4,	 35.7,	 36.5,	
49.4(2),	 51.5(2),	 65.4(2),	 68.7,	 68.8,	 69.0,	 70.8,	 74.4	 (dd,	 2JC-F	
33.0,	25.6),	76.0	(dd,	2JC-F	33.7,	24.9),	80.6,	80.9,	96.0,	121.7(m),	









borohydride	 (9	mg,	0.23	mmol)	was	added	 to	 the	aldehyde	90	
(0.14	g,	0.19	mmol)	 in	MeOH	 (2.0	mL)	at	0	 °C	and	 the	mixture	
stirred	 for	 1	 h.	 Aqueous	 hydrogen	 chloride	 (10%,	 10	 mL)	 was	
added	 at	 0	 °C	 followed	 by	 EtOAc	 (10	mL).	 The	 aqueous	 phase	
was	extracted	with	EtOAc	 (3	×	10	mL)	and	the	organic	extracts	
were	 washed	 with	 brine	 (40	 mL),	 dried	 (MgSO4)	 and	
concentrated	 under	 reduced	 pressure.	 Chromatography	 of	 the	
residue	 (10:90	 to	 30:70	 ether:light	 petroleum)	 gave	 the	 title	
compound	 91	 (0.12	 g,	 0.16	 mmol,	 83%)	 as	 a	 colourless	 oil,	 a	
50:50	mixture	 of	 diastereoisomers	 (19F	 NMR),	Rf	 =	 0.18	 (40:60	
ether:light	petroleum),	[α]D28	=	-11.7	(c	1.8,	ether)	(Found:	M+	+	
H,	 729.4387.	 C34H71O8F2Si3	 requires	 M,	 729.4419);	 nmax/cm-1	













6.26	 (0.5	 H,	 d,	 J	 2.6,	 2-H);	 δC	 (100	 MHz,	 CDCl3)	 -4.8,	 -4.7(2),	
-4.6,	-4.1,	-4.0,	-1.5(2),	17.2,	17.3,	18.0,	18.1,	20.1	(t,	4JC-F	4.4),	
20.5	 (t,	 4JC-F	 3.7),	 22.9	 (d,	 4JC-F	 5.1),	 23.5	 (d,	 4JC-F	 4.4),	 26.0(3),	
35.6,	35.7,	36.2,	36.3,	38.9,	39.2,	51.4,	65.3,	65.8,	68.9(2),	69.1,	
70.1,	 72.0	 (d,	 5JC-F	 2.2),	 72.4	 (d,	 5JC-F	 2.2),	 75.6	 (dd,	 2JC-F	 31.5,	
25.6),	78.4	(dd,	2JC-F	32.2,	25.6),	80.4(2),	95.8,	95.9,	121.8	(t,	3JC-F	
9.5),	 122.7	 (dd,	 3JC-F	 11.7,	 6.6),	 122.7	 and	 123.4	 (each	 dd,	 1JC-F	
258.2,	 245.8),	 149.6	 (dd,	 2JC-F	 23.5,	 21.3),	 151.3	 (dd,	 2JC-F	 24.9,	
20.5),	 165.9	 and	166.0;	 δF	 (377	MHz,	 CDCl3)	-115.99,	-114.44,	







Trichlorobenzoyl	 chloride	 (0.018	 mL,	 0.11	 mmol)	 and	
triethylamine	 (0.034	 mL,	 0.24	 mmol)	 were	 added	 to	 the	
carboxylic	 acid	98	 (38	mg,	0.11	mmol)	 in	 toluene	 (0.3	mL)	 and	
the	mixture	 stirred	 for	1.5	h.	The	diol	91	 (68	mg,	0.093	mmol)	
and	 DMAP	 (11	 mg,	 0.093	 mmol)	 in	 toluene	 (1.45	 mL)	 were	






the	 aqueous	 phase	was	 extracted	with	 ether	 (3	 ×	 10	mL).	 The	
organic	extracts	were	washed	with	brine	(40	mL),	dried	(MgSO4)	
and	concentrated	under	 reduced	pressure	 to	give	 the	ester	92	
(0.10	g)	as	a	mixture	of	diastereoisomers	used	without	 further	
purification,	Rf	=	0.38	(40:60	ether:light	petroleum).	
	 This	 ester	 92	 was	 taken	 up	 in	 DCM	 (1.6	 mL)	 and	 4Å	
molecular	sieves	(75	mg),	N-methylmorpholine-N-oxide	(22	mg,	
0.17	 mmol)	 and	 TPAP	 (5	 mg,	 0.013	 mmol)	 were	 added.	 After	
stirring	 at	 rt	 for	 16	 h,	 the	 reaction	 mixture	 was	 concentrated	
under	 reduced	 pressure.	 Chromatography	 of	 the	 residue	 that	
had	been	dry-loaded	onto	the	column	(5:95	to	10:90	ether:light	
petroleum)	 gave	 the	 title	 compound	 93	 (56	 mg,	 0.053	 mmol,	
57%	from	diol	91)	as	a	colourless	oil,	Rf	=	0.18	(20:80	ether:light	
petroleum),	 [α]D29	 =	-11.4	 (c	3.6,	 ether);	nmax/cm-1	 2953,	 2929,	
2857,	 1760,	 1730,	 1602,	 1472,	 1452,	 1370,	 1300,	 1249,	 1153,	
1098,	1076,	1051,	1032,	933,	833	and	809;	δH	(400	MHz,	CDCl3)	




H2),	 3.03	 (2	 H,	 t,	 J	 6.6,	 CH2CO2CH2CCl3),	 3.46	 (1	 H,	 m,	





(100	 MHz,	 CDCl3)	 -4.8,	 -4.7,	 -4.1,	 -1.5,	 17.1,	 17.9,	 18.1,	
21.9(m),	25.9(2),	34.0,	35.7,	36.0,	47.8,	51.5,	64.1,	65.1,	69.1(2),	















washed	 with	 brine	 (40	 mL),	 dried	 (MgSO4)	 and	 concentrated	
under	reduced	pressure.	Chromatography	of	the	residue	(10:90	
ether:light	petroleum)	gave	the	title	compound	94	(54	mg,	0.06	
mmol,	 65%)	 as	 a	 colourless	 oil,	 Rf	 =	 0.33	 (40:60	 ether:light	
petroleum),	 [α]D30	 =	 +0.50	 (c	 2.0,	 ether);	nmax/cm-1	 2953,	 2929,	
2856,	 1759,	 1731,	 1601,	 1491,	 1472,	 1452,	 1370,	 1300,	 1250,	













169.3	and	200.5	 (t,	 2JC-F	 29.9);	 δF	 (471	MHz,	CDCl3)	-102.07	 (d,	
2JF-F	275.9)	and	-100.55	 (d,	 2JF-F	274.2);	m/z	 (ES+)	942	 (M+	+	23,	
80%).	
	 Zinc	dust	(7	mg)	and	PPTS	(14	mg,	0.055	mmol)	were	added	
to	 the	 ester	 94	 (20	mg,	 0.022	mmol)	 in	 THF	 (0.4	mL)	 and	 the	
mixture	 heated	 under	 reflux	 for	 30	 min.	 Saturated	 aqueous	
ammonium	 chloride	 (10	 mL)	 was	 added	 and	 the	 mixture	 was	
extracted	 with	 EtOAc	 (4	 ×	 10	 mL).	 The	 organic	 extracts	 were	
washed	 with	 brine	 (40	 mL),	 dried	 (MgSO4)	 and	 concentrated	
under	 reduced	 pressure	 to	 give	 the	 acid	 95.	 This	 acid	 was	
dissolved	in	benzene	(0.26	mL).	Pyridine	(5	µL,	0.063	mmol)	and	
2,4,6-trichlorobenzoyl	 chloride	 (3	µL,	 0.016	mmol)	were	added	
and	 the	 mixture	 was	 stirred	 for	 45	 min	 at	 rt	 then	 added	 to	
DMAP	(16	mg,	0.13	mmol)	in	benzene	(2.8	mL).	The	mixture	was	
heated	at	 60	 oC	 for	 16	h	 then	 cooled	 to	 rt.	 Saturated	aqueous	
ammonium	 chloride	 (10	 mL)	 was	 added	 and	 the	 mixture	 was	
extracted	 with	 EtOAc	 (4	 ×	 10	 mL).	 The	 organic	 extracts	 were	
washed	 with	 brine	 (40	 mL),	 dried	 (MgSO4)	 and	 concentrated	
under	reduced	pressure	to	give	an	impure	product	provisionally	
identified	as	 the	acrylate	96	 (29	mg);	δH	 (400	MHz,	CDCl3)	0.05	
(12	H,	overlapping	s,	4	×	SiCH3),	1.15	(3	H,	d,	J	7.0,	9-H3),	1.24	[18	
H,	s,	2	×	SiC(CH3)3],	1.33	and	1.34	(each	3	H,	s,	3’-CH3),	1.65	(2	H,	






attempted	 at	 rt,	 the	 acrylate	 96	 was	 detected	 by	 TLC	 10	 min	
after	adding	the	mixture	to	the	DMAP.			
	
	 2-(2,2,2-Trichloroethoxycarbonylethoxy)benzoic	 acid	 (98).	




for	 1	 h.	 2-Methylbut-2-ene	 (3.1	mL,	 29.16	mmol),	 water	 (0.96	
mL)	 and	 NaH2PO4	 (0.713	 g,	 5.94	 mmol)	 were	 added.	 After	
cooling	 the	 mixture	 to	 0	 °C,	 NaClO2	 (0.43	 g,	 4.75	 mmol)	 was	
added	and	the	deep	red	solution	was	stirred	for	1	h.	Saturated	
aqueous	 sodium	 thiosulfate	 (20	 mL)	 and	 EtOAc	 (20	 mL)	 were	
added	and	the	aqueous	phase	was	extracted	into	EtOAc	(3	×	20	
mL).	The	organic	extracts	were	washed	with	brine	(80	mL),	dried	
(MgSO4)	 and	 concentrated	 under	 reduced	 pressure.	 2,2,2-
Trichloroethanol	 (0.086	 mL,	 0.89	 mmol),	 DCC	 (0.185	 g,	 0.89	
mmol)	 and	 DMAP	 (0.11	 g,	 0.89	 mmol)	 were	 added	 to	 the	
residue	in	dry	DCM	(3.1	mL)	and	the	mixture	stirred	at	rt	for	16	
h.	After	concentration	under	reduced	pressure,	chromatography	
of	 the	 residue	 with	 dry-loading	 (2:98	 to	 5:95	 EtOAc:light	
petroleum)	 gave	 the	 ester	 97	 (0.16	 g,	 0.44	 mmol,	 73%	 as	 a	
colourless	 oil,	Rf	 =	 0.56	 (40:60	 EtOAc:light	 petroleum)	 (Found:	










MHz,	 CDCl3)	 34.2,	 51.9,	 64.2,	 74.0,	 94.6,	 113.7,	 120.7,	 120.9,	
131.6,	133.4,	157.7,	166.6	and	169.2;	m/z	 (ES+)	376.9	(M+	+	23,	
70%	and	355.0	(M+	+	1,	100).		
	 Sodium	 iodide	 (0.265	 g,	 1.77	 mmol)	 and	 trimethylsilyl	
chloride	 (0.09	 mL,	 0.71	 mmol)	 were	 added	 to	 this	 ester	 97	
(0.126	 g,	 0.354	mmol)	 in	 1,2-dichloroethane	 (3.6	 mL)	 and	 the	
solution	heated	at	100	°C	for	15	h	then	cooled	and	concentrated	
under	 reduced	 pressure.	 Chromatography	 of	 the	 residue	 with	
dry-loading	 (5:95	 to	 20:80	 EtOAc:light	 petroleum	 with	 0.1%	
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